ROBERT C. Martin, II, MD, PhD - University of Louisville Public [PDF]

CURRICULUM VITAE

January 5th, 2014

Name:

ROBERT C. G. MARTIN, II, MD, PHD

Office address:

Division of Surgical Oncology University of Louisville 315 East Broadway, #313 Louisville, KY 40202 Phone: (502) 629-3355 Fax: (502) 629-3030 E-mail: [email protected]

Home address:

3705 Pennington Lane Louisville, KY 40207

Date of Birth:

May 16, 1968

Place of Birth:

Louisville, Kentucky

Marital Status:

Married: Sarah P. Martin, MeD Children: Cora H. Martin Clare V. Martin Christine J. Martin

Education:

Georgetown University Major: Mathematics Washington, DC Degree: BSc

1986-1990

University of Louisville School of Medicine Louisville, Kentucky Degree: MD

1991-1995

University of Louisville School of Medicine Department of Pharmacology and Toxicology Louisville, KY Degree: PhD

2003-2008

Endowed Professorship:

Sam and Lolita Weakley Endowed Chair in Surgical Oncology Department of Surgery University of Louisville

Faculty Appointments:

Graduate Research Training Faculty

2011- Present

10/13-Present 1

CURRICULUM VITAE

January 5th, 2014

Member of the Graduate Faculty University of Louisville School of Medicine Associate Professor of Pharmacology & Toxicology University of Louisville School of Medicine J. Graham Brown Cancer Center

9/2013-Present

Professor of Surgery University of Louisville Department of Surgery University of Louisville Louisville, KY

7/2011-Present

Director Division of Surgical Oncology Department of Surgery University of Louisville Louisville, KY

4/2008-Present

Associate Professor of Surgery Division of Surgical Oncology University of Louisville J. Graham Brown Cancer Center

7/2007-6/2011

Assistant Professor of Surgery Division of Surgical Oncology University of Louisville J. Graham Brown Cancer Center

7/2002- 6/2007

Internship:

University of Louisville Hospital Louisville, Kentucky Surgery

1995-1996

Residency:

Department of Surgery University of Louisville School of Medicine Louisville, Kentucky

1996-1999

Chief Administrative Resident: Department of Surgery University of Louisville Louisville, Kentucky 2

1999-2000

CURRICULUM VITAE Fellowship:

January 5th, 2014

Surgical Oncology Fellow Memorial Sloan Kettering

2000-2002

Hepatobiliary Fellow Memorial Sloan-Kettering

2001-2002

Certification:

American Board of Surgery - #46569 Recertified

10/29/2001 12/11/2010

Licensure:

Kentucky- #32503 New York - #218879

Honors/Awards:

Charles M. Edelen Award Best Publication by a Resident

2000

John W. Price Award Excellence in undergraduate instruction

2000

William L. Brohm Award Outstanding Overall Performance Resident

2000

Career Development Award The Society for Surgical of the Alimentary Tract

2004-2006

Hiram C. Polk, Jr. Surgical Award Resident Education chosen by the graduating Chief Residents

2006

Nominated “Faculty Favorite” Delphi Center for Teaching/Learning

2007

America’s Top Surgeon Best Doctor 2007-2008

2008

Patients' Choice Award Nation's most beloved doctors, patients

2008

2009 Top Doctors Louisville Magazine!

2009

Who’s Who in America 2009 Patients Choice Physician

2009 2009 3

CURRICULUM VITAE

January 5th, 2014

Cancer Liaison Physician (CLP) Outstanding Performance Award

2010

America’s Top Oncologist Honor of Distinction and Excellence

2010

America’s Most Compassionate Doctors

2010

America’s Top Surgeons 2011-2012

2011-2012

Best Doctors Louisville Magazine

2012, 2013

Alpha Omega Alpha Honor Medical Society

2012

Best 2011 JOGS Best Article Award Winner Analysis of 6,747 Pancreatic Neuroendocrine Tumors for a Proposed Staging System

2012

69th Samuel David Gross Lectureship Chemoprevention in Esophageal and Hepatocellular Cancer

2013

Southeastern Surgical Congress Continuing Medical Education Comm Chair Program and CME Committee

1998 2009-2013 2013-2014

Society of American Gastrointestinal Endoscopic Surgeons

1998

American Medical Association

1991

American Hepato-Pancreato-Biliary Association Membership Committee Development Committee International Relations Committee Chair, Professional and Development Committee Executive Council Member

2002 2005-2007 2007-present 2008-present 2010-2012

National Committees:

4

2010-Present

CURRICULUM VITAE

January 5th, 2014

International Hepato-Pancreatico-Biliary Association Corporate Relations Committee

2009-present 2009

The Society for Surgery of the Alimentary Tract Hepatobiliary Program Committee

2000 2010

The Society of Surgical Oncology Training Program Directors Subcommittee Website Committee Chair of the Corporate Relations Committee Continuing Medical Education Committee Chair of the Needs Assessment/Practice Gaps Workgroup Executive Council Member James Ewing Foundation Treasurer

2000 2006 2008 2009-Present 2009 2011-2013

The American Society of Clinical Oncology

2000

American Association for Cancer Research

2002

American College of Surgeons Oncology Group Physician Group Leader Fellow Member

2003 2004 2000

Association for Academic Surgery The Leadership Council Ethics Committee

2004 2008-2010 2011-2013

The Society of University Surgeons The Membership Committee

2005 2010-2013

The Western Surgical Association

2005

The Southwestern Surgical Congress

2008

The Southern Surgical Association

2008

The Central Surgical Association Program Committee

2008 2012-Present

2013-2016 2011-Present

5

CURRICULUM VITAE

Local/State:

January 5th, 2014

The American Association Surgical Association

2012

The Cholangiocarcinoma Foundation Medical Advisory Committee

2013

Jefferson County Medical Association

1995-present

Georgetown Alumni Admissions

1998-present

University of Louisville School of Medicine Admissions Committee Graduate Medical Committee House Staff Council

6

1992-1995 1999-2000

Kentucky Medical Association Manpower Committee Cancer Committee Chairman

1991-present 1991-1994 2002-present 2006-present

Hiram C. Polk Surgical Society Secretary

2000-present 2009-present

Louisville Surgical Society President

2002-present 2011

Cancer Liaison University of Louisville Hospital

2002-present

James Graham Brown Cancer Center Cancer Committee Chair Subcommittee: 2003 BCC Annual Report Chair Subcommittee: Conferences Cancer Prevention and Control Program

2002-present 2004 2004-present 2003-present

Physician in Charge Tumor Board

2002-present

The American Cancer Society Colorectal Screening Committee Kentucky Physician’s Workgroup

2003-present 2004-Present

Norton Health Care Director Upper Gastrointestinal & HepatoPancreatico-Biliary Conference Norton Hospital

2004-present

CURRICULUM VITAE

January 5th, 2014

Cancer Liaison Norton Hospital Committee on Cancer Cancer Liaison Outstanding Performance Award Leadership: Network Designation Committee on Cancer Physician Advisory Committee Colonoscopy Screening Initiative

2002-present 2010 2005-2006 2006-present

Norton Cancer Institute Advisory Board

2007-present

Center for Genetics and Molecular Medicine: Genetic Susceptibility and Biomarkers Core

2004-present

Director Upper Gastrointestinal and HepatoPancreaticoBiliary Multidisciplinary Clinic and Conference James Graham Brown Cancer Center

2005- present

University of Louisville Resident Conference Director

2005-Present

University of Louisville Hospital Medical Staff Bylaws Committee

2006

Director of Surgical Resident Curriculum

2005-2010

Co-Director Surgical Oncology Journal Club for Surgical Residents

2004-Present

Director Upper Gastrointestinal and HepatoPancreatico- Biliary Multidisciplinary Clinic and Conference James Graham Brown Cancer Center

2005-Present

Co-Director of the Society of Surgical Oncology Accredited 2-Year Surgical Oncology Fellowship Program

2005-Present

One Hour Lectures on Liver and Spleen to Third Year Medical Students Each 8-Week Surgery Rotation 2002-2010 7

January 5th, 2014

CURRICULUM VITAE One Hour Lecture on Pancreas to Third year Medical Students Each 8-Week Surgery Rotation

2002-2010

Participate in Third Year Oral Exams Each 8-Week Surgery Rotation

2002-Present

Journal Club for Senior Honors Students

2003

Mentoring:

Name of Mentees

Medical Student, Resident, Fellow, Pre- or Post-docTraining Period Prior Academic Degree

Title of Research Project(s) Current Posi

Ryaz Chagpar Pre

6/25/2005 toBS 9/1/2005 MSc

2003

University of Factors associated withSurgical Res Saskatchewan improved survival among University o young adult melanomaVancouver, patients despite a greater Columbia incidence of sentinel lymph node metastasis.

Angela Michelle Post Lewis

07/01/05 to BS 06/30/07 MD

1999 2000

Temple University Analysis of DNA adducts Private pract and DNA damage in Portland Cli thyroid disease and thyroid Oregon, Sur cancer Oncology

Charles E. Woodall Post

07/01/06 to BLA 06/30/08 MD

Dec 2000 University of Accurate nodal stagingInstructor, and E May 2001 Missouri-Kansas imaging characteristics(ERCP), to De City predict overall survivalof Surgery, University o Louisville, K

Nathan Reuter Post

07/01/2007 to BA 06/30/2009 MD

May 1998 University of North Use of adjuvant Current Surg May 2002 Dakota chemotherapy in young Oncology Fe women with node-negative Source of Su ER+ breast cancer: refining James Graha the use of recurrence score Cancer - Cent a decision analysis. Louisville, K

Matthew R. Bower Post

07/01/2008 to BS 06/30/2010 MD

May 1999 University Texas Chemoprotective Effects Current of Surg June 2003 Southwestern Curcumin in Esophageal Oncology Fe Epithelial Cells Exposed Source to of Su Bile Acids James Graha

8

January 5th, 2014

CURRICULUM VITAE

Cancer Cent Louisville, K Christine Landry Post

7/1/2004 to MD (resident) 2008 7/1/2008

University of Analysis of carcinoid Surgical Onc Louisville tumors Fellow, MD Anderson, H Texas

Harini Aiyer Post

2007-2011 PhD

University of Prevention of reflux- Research Po Kentucky induced esophageal Georgetown adenocarcinoma by dietary University berries

Yan Li

2003-currentMD, PhD 1998

Post

2007

Cheng Du University Optimal Esophageal Current Assi of Chinese Medicine Animal Modeling Clinical Prof Research Division of S Oncology

Kalista HughesMed Student

6/1/03-8/15/03 BS

5/2002 UL

MnSOD and Gastric Cancer Internal Med Resident

Amanda Bressler PGY1

7/1/07 to 6/30/08 M.D. BS

5/2007 UL 2002 UK

MnSOD expression inOb/Gyn Res Pancreatic Cancer Good Samar Cincinnati, O

Ryan Duvall Med Student

6/1/20078/15/2007

BS

5/2005 UL

Jennifer Lohle Med Student

6/1/20068/15/2006

BS

5/2004 UL

Kentucky Hepatoma: Ob/Gyn Res epidemiological variant Good or Samar same problem differentCincinnati, O region?

Ryan Whitney Med Student 1st-4th 6/15/2008- BS Present

5/2007 UL

The Use of Self-Expanding Current Thir Silicone Stents in Medical Stu Esophageal Strictures: Less Cost and More Efficiency

Jonathan Joshi Post Med School6/1/2008-7/1/2009 1 MD

5/2008 UL

Hepatic Intra-arterial PGY-1 Depa injection of IrinotecanRadiology Drug Eluting Beads in Unresectable Colorectal Liver Metastatic Refractory to Standard Systemic Chemotherapy: Results of 9

January 5th, 2014

CURRICULUM VITAE

Multi-Institutional Study Bruce Herrmann Res

07/1/02 to M.D. 6/30/07 BS

2002 1998

Texas Tech Association of Manganese Plastic Surge Baylor University Superoxide DismutaseFellowship – Expression with Chattanooga Progression of Carcinogenesis in Barrett’s Esophagus. **Charles M. Edelen Award Winner: Best publication by a resident.

Vedra Augenstein Res

07/1/05 to MD 6/30/10 BS

2005

UL UL

The Quality of Survival PGY-5 Chie Reporting in Chemotherapy Resident and Surgery Trials in Metastatic Colorectal Cancer. **Publication: Cancer 2006;106:1389-1394.

Sebastian Eid Res

07/1/05 to MD 6/30/10 BS

2005 2001

UL UL

Assessment of symptom PGY-5 Chie experience in patients Resident undergoing hepatic resection or ablation. **Publication: Cancer 2006;107:2715-2720.

Chinmaya Shelgikar Res

7/1/ 2001 to MD 6/30/07 (research year at Emory 7/04 BS to7/05)

2001

Empiric Antibiotics for Medical CollegeTransarterial of Embolization Private Prac Wisconsin in Hepatocellular Arbor, MICH Univ of Wisc, Mad Carcinoma: Indicated? **Publication: Am Surg 2007

Benjamin Vessels Res

7/1/2008 – BS 5/15/2009

Russell Brown Fellow

7/1/2009 – MD 1/1/2010

10

2003

UL

The role of esophagealResident stents in the nutritional support of patients with esophageal malignancy

Theramal Resistance Second Yr S Effects of Hepatocellular Fellow UL

January 5th, 2014

CURRICULUM VITAE

Cancer Nick Harper Undergraduate 5/3/2010 – BS – Pending 2011 8/15/2010

Bellarmine

EGFR expression in Barrett’s Esophagus

Daniel Malik Undergraduate 5/15/2009 – BS – Pending 2011 5/5/2010

UL

MnSOD expression in smoke exposed Barrett’s Esophagus

Andrew Ramsey Medical Student6/1/2010 1st – MD- Pending 2014 8/12/2010

UL

BMI as a predictor of outcomes following pancreatectomy

Suzanne Schiffman Resident – PGY3 7/1/2009 – MD Research Fellow6/30/2010

2007

U of Pitt

Intrahepatic Surg Onc Re Cholangiocarcinoma and Fellow molecular predictors of ourcome

Charles R. St. Hill Surgical Oncology 7/1/2010 – MD Fellow 6/30/2012

2005

U Nevada Las Vegas Efficacy of LEDC Ablation Assistant Pro on Human Pancreatic Surgery UN Adenocarcinoma in a Murine Model

Russell FarmerResident – PGY3 7/1/20106/30/2011

MD

2004

U of Texas

Surg Onc Re Fellow

Mohsen Hasanin Medical Student11/1/2010 – MD 12/31/2010

2010

Cairo University Surgical Oncology outcomes

Surg Onc M Student rota

Amanda MillerMedical Student5/14/2011- BS 8/12/2011

2004

Quality if life after major Second Year hepatectomy Student

Nsehniitooh Mbah Medical Student5/14/2011- BS 4/12/2014

2004

3 publications: Optimal Second Year Transection for Student Laparoscopic Liver

Robert M Cannon Resident – PGY3/4/2011 2– – MD Research 6/30/2012

2007

U of Georgia 5 Publications: Laparoscopic Liver Resection

Third Year S Resident

Thomas Lee Resident – PGY5/4/20112– Research 6/30/2012

MD

3 Publications: QualityThird Year S Factors in Readmission Resident following Surgical Oncology Procedures

Matthew Fox Resident – PGY3 5/5/2010– Research 6/30/2011

MD

3 Publications: Optimal Fourth Year Surgical Outcomes in Resident Pulmonary Carcinoids 11

January 5th, 2014

CURRICULUM VITAE Eric Dunki-Jacobs Surgical Oncology 7/1/2011Fellow 6/30/2012

MD

Rafi Kotoyan Third Year Medical 5/5/2011Student 12/2/2012

MD

Scott Tatum

Third Year Medical 5/5/2011 – BS Student 12/2/2012 MD

U of Cincinnati

First Year S Onc Fellow

Hepatic Arterial Therapy General in Surg Met Pancreatic CancerResident UN 2012

Hepatic Arterial Therapy Radiology in R U of Louisville Met GE Junction Cancer

Rhodes BrownUndergraduate 6/2012-8/2012 BS (pending) 2013

William and Lee Optimal Management Undergrad of S College Liver Dominant Breast Cancer

Nicholas Burnett First Year Student 6/2012-8/2012 BS MD

2011 2015

Optimal Staging in HCC R25 NIH Su U of Louisville Pubs Below:243 Student

Ryan AndersonFirst year Student 6/2012-8/2012 BS MD

2011 2015

Pancreatic fistula U of Louisville prevention with somatostatin

Vanessa StatesUndergraduate 6/2012- 8/2012 BS Jacob EdwardsFirst Year Medical 9/12 to 5/13 BS Student

R25 NIH Su Student

R25 NIH Su Student 2011

Combined Liver and Pancreatic Resections: Safety and Outcomes

Elizabeth First Year Student 6/2013-5/2014 BS Bruenderman

Optimal Pancreatic R25 NIH Su Screening and Cost forStudent Pancretic Adenocarcinoma Prevention

Alan North

First Year Student 6/2013-5/2014 BS

2012

Microwave Ablation: R25 NIH Su Optimal quality and Student presentation

John Wehry

First Year Student 6/2013-5/2014 BS

2012

Allogenic Blood R25 NIH Su Transfusion in Surgical Student Oncology

Xuanyi (Selina)Pre-Doctoral Li Student 6/2011-6/2014 BS

2010

Ohio State University

Alexandria Oliver Pre-Doctoral

2012

Mercer University PK data for DEBDOXMasters use Biophysiolo

1/2014-7/2015 BS

Dissertation Committee Work: Chair Dissertation Committee for 2008 Masters Program: 12

Berry Gavage and Liver Dental Stude protection

2008

CURRICULUM VITAE

January 5th, 2014

Charles W. Woodall, MD: Research proposal Yttrium-90 Intra-Arterial Brachytherapy for Unresectable Hepatocellular Cancer with Portal Vein or Inferior Vena Cava Thrombosis: Safe and Clinically Beneficial? Member Dissertation Committee for 2008 Masters Program:

2008

Benjamin Vessels, MD: Research Proposal The Multidisciplinary Use of Esophageal Stenting Mentor of PhD Doctoral Candidate Pharmacology and Toxicology: Harshul Pandit 2013Present Clinical Service Activities:

Director Upper Gastrointestinal and Hepato Pancreatico-Biliary Multidisciplinary Clinic And Conference James Graham Brown Cancer Center

2005-

Establishing an specialized practice in Upper Gastrointestinal and Hepato-Pancreatico-Biliary Cancers with RVU average billing of 15,750 per year (> 95% benchmark averages for Surgeons)

2002-

Established TheraSphere program for Unresectable Hepatocellular Cancers and Compassionate Use for Metastatic Cancers To Liver

2004-

Established the only intraoperative MRI-guided Liver ablation center in the region

2002-2005

Established only Microwave Ablation Center in Region

2003-

Present

Present

Present

Present 13

CURRICULUM VITAE

January 5th, 2014

Established only LC Bead, Drug-Eluting Bead Treatment Center in region

2005-

Course Director: Laparoscopic Liver Resection Course – Nine visiting surgeons From the United States attended to learn my Technique of laparoscopic liver resection

November

Invited Faculty: Advanced Upper Abdominal & Bowel Cadaver Surgery Instructed 17 gynecologist oncologists in Hepatic resection, ablation and bowel resection Techniques

May 17-

Present

9, 2007

18, 2008 Course Director: First Ever Microwave Ablation Course: Basic physics Preoperative, intraoperative And Postoperative techniques Twenty visiting surgeons and interventional Radiologists/oncologists from the United States April 15, 2008 Attended to learn my technique of microwave

June 20,

Ablation – Three separate courses

August 15,

Course Director: Microwave Ablation and Ultrasound Workshop Trained 21 separate surgeons on advanced Hepatic ultrasound and microwave ablation

July 22-24,

2008 2008

2009

Course Director of the Only Irreversible 14

CURRICULUM VITAE

January 5th, 2014

Electroporation Physician Training Workshop: 2009: October 10th, 2009, November 11th, 2009, 2010: February 12th, 2010, February 19th, 2010, March 26th, 2010, May 7th, 2010, May 21st, 2010, Sept 4th, 2010, Oct 15th, 2010, Nov 3rd, 2010, Nov 12th, 2010, Dec 17th, 2010, 2011: 1/7, 2/11,2/22, 3/1, 3/25,5/20, 6/17, 7/8, 8/26, 9/30, 10/14, 11/4, 12/9 - Total trained 95 Surgeons/ Interventional Oncologist from the United States and Taiwan on the Pre-Clinical, Clinical, and Hands on Use of Irreversible Electroporation in the NonThermal Soft Tissue Ablation 2012: 1/13, 2/24, 5/18, 5/25, 6/19, 8/24, 10/5, 11/16, and 12/14 - Total of 100 Surgeons/ Interventional Oncologist from the United States and Taiwan on the Pre-Clinical, Clinical, and Hands On Use of Irreversible Electroporation In the NonThermal Soft Tissue Ablation 2013: Jan, Feb, March, April, May, June, July, August, Sept, Oct, Nov, and Dec - Total of 75 Surgeons/ Interventional Oncologist from the United States and Taiwan on the Pre-Clinical, Clinical, and Hands On Use of Irreversible Electroporation In the NonThermal Soft Tissue Ablation Course Director of the Only Irreversible Electroporation Human Case Observations: 2010: Aug 4th, 2010, Sept 22nd, 2010, Oct 13th, 2010, Nov 3rd, 2011, Dec 1st, 2010 2011: 7/27, 8/24, 9/7, 9/28, 10/12, 11/2, 12/7 -Total of 60 Surgeons trained the actual use and safety of the device from The United States, France, and Japan 2012: 1/11, 2/29, 5/23, 7/11, 8/22, 9/26, 10/24, 11/14, and 12/12 -Total of 45 Surgeons trained the actual use and safety of the device from The United States 2013 : Jan, Feb, March, April, May, June, July, August, Sept, Oct, Nov, and Dec - a total of 48 Surgeons from USA, Denmark, Czech Republic, and other European Countries trained for the Actual use and Safety of the Device in the United States : Jan, Feb, March, April, May, June, July, August, Sept, Oct, Nov, and Dec - a total of 48 Surgeons trained for the Actual use and Safety of the Device in the United States 15

CURRICULUM VITAE

January 5th, 2014

Co-Course Director of Laparoscopic Liver, Pancreatic, Gastric and Esophageal Surgery Human Case Observation Course: 2012: - Total of 12 Surgeons from across the United States have traveled to observe and learn minimally invasive techniques for laparoscopic liver, pancreatic, gastric and esophageal resections. RESEARCH FUNDING: Grants Completed 1.

Role: Principal Investigator 3/13/2003 Codman: Johnson and Johnson Unrestricted Educational Grant for Hepatobiliary Disease Management Team and Screening. $15,000

2.

Role: Principal Investigator 7/1/2003-6/30/2004 James Graham Brown Cancer Center: Cancer Research Pilot Projects. Genetic Polymorphisms in Manganese Superoxide Dismutase (MnSOD) as a Predictor of Lung Cancer. $31,596.

3.

Role: Principal Investigator 7/1/2003-6/30/2004 James Graham Brown Cancer Center: Microarray Pilot Project Program. Expression Profiles of Barrett’s Esophagus using Laser Capture Microdissection: Evaluating Predictors for Malignancy. $30,000.

4.

Role: Principal Investigator 7/1/2004-6/30/2006 Society for the Surgery of the Alimentary Tract: Career Development Award. Oxidative Stress in the Progression of Barrett’s Esophagus to Adenocarcinoma Utilizing a Novel External Esophageal Perfusion Model. $80,000.

5.

Role: Co- Investigator 7/1/2004-6/30/2006 Pharmacogenetics of drug and carcinogen metabolism. Activities to Promote Research Collaborations: supplement to NCI parent grant (R01-CA34627). $113,750.

6.

Role: Principal Investigator 5/1/2006 – 9/30/2006 James Brown Cancer Center MicroPet Pilot Project Evaluation of Barrett’s Metaplasia and Esophageal Adenocarcinoma by Micro-PET Scan in Esophagoduodenal Anastomosis Rat Model. $30,000.

7.

Role: Principal Investigator 7/1/2006 – 10/30/2006

16

CURRICULUM VITAE

January 5th, 2014

School of Medicine Grant MnSOD Therapy in the prevention of adenocarcinoma in a rat model of Barrett’s esophagus. $15,000. 8.

Role: Principal Investigator 10/1/2008 to 9/30/2010 NIH RO3 CA137801-01 Prevention of Reflux Induced Esophageal Adenocarcinoma by Dietary Berries. $145,000

9.

Role: Principal Investigator Robert C.G. Martin 7/1/2010 – 12/31/2011 CLINICAL AND TRANSLATIONAL SCIENCE PILOT GRANT PROGRAM Title of Innovative Award: Validated Animal Model to Identify Novel Predictors of Barrett's Progression into Cancer $175,000

10.

Role: Co-Principal Investigator 3/29/2010 to 4/30/2012 Wallace H Coulter Foundation Chitosan Modified NIR Absorbing gold nanoparticles for increasing efficacy of treatment of hepatocellular cancer $240,000 Current Grant Funding & Clinical Trials

1.

Role: Principal Investigator 7/1/2007 to Present Unrestricted Education Grant: AngioDynamics/ Biocompatibles Evaluation of Precision Hepatic Arterial Therapy for Primary and Metastatic Liver Tumors $1,650,000.

2.

Role: Sponsor – Principal Investigator Co-Investigator 6/1/2010 – 6/30/2010 Biocompatibles Foundation Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Unresectable Intrahepatic Cholangiocarcinoma (ICC) with Concomitant Systemic Gemcitabine and Cisplatin (Gem-Cis) Pilot $32,100 Initial Phase 2: $126,000 Second Phase 2: $640,000

3.

Role: Principal Investigator 10/1/2010 to Present Unrestricted Education Grant: AngioDynamics/ Biocompatibles Evaluation of Soft Tissue Ablation for Cancers $950,000

4.

Role: Participating Faculty Mentor (PI: Hein DW) University of Louisville Cancer Education Program 17

CURRICULUM VITAE Funding Agency: Project Period:

January 5th, 2014

NIH/NCI (R25-CA134283) September 14, 2011 to August 31, 2016

5.

Role: Martin (PI) (Biocompatibles, Investigator Initiated) - 4/18/2009-12/31/2014 FDA: IDE Submission #G080230-S001 Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis from Colon Cancer with Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin chemotherapy, and anti-Angiogenic Therapy Phase 1: $188,000 Phase 2: $1,250,000

6.

Role: Martin (PI) (Sirtex Initiated Phase III Study) – 6/2006 to Present Prospective Randomized Phase 3 Trial using Folfox-based chemotherapy in combination with SirSphere® liver-directed radiation therapy to treat metastatic colorectal cancer. Phase III - $265,000

7.

Role: Martin (PI) (MDS Nordion Phase II Study) – 1/2013 to Present TS-102 trial is a randomized phase III study evaluating the use of Yttrium-90 drug eluting beads in combination with standard of care chemotherapy (FOLFOX or FOLFIRI) versus chemotherapy alone. Phase II - $295,000

8.

Role: Martin (PI) (MDS Nordion Phase III Study) – 1/2013 to Present This randomized phase III trial will evaluate the overall survival of Yttrium-90 drug-eluting beads in combination with sorafenib versus sorafenib alone in the treatment of patients with unresectable hepatocellular carcinoma. Phase III - $195,000

9.

Role: Martin (PI)Investigator Initiated Study - 1/2013 to Present GERD-Related Symptom Assessment in Subjects with Malignant Dysphagia Receiving Esophageal Stents. Pilot - $9000 Longer Term Study: $9000 Completed Clinical Trials

10.

18

(Biocompatibles, Investigator Initiated) Martin (PI) - 10/1/2009-8/2012 FDA: IDE Submission #G090097/S001 Transcatheter arterial chemoembolization (TACE) with doxorubicin-loaded LC beads in the treatment of liver metastases in patients with stage IV metastatic melanoma: A multicenter pilot non-randomized, feasibility trial $467,000

CURRICULUM VITAE

January 5th, 2014

11.

(Bayer, Industry Sponsored) Martin (PI) - 9/1/2009-6/2012 A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation” (the “STORM – Adjuvant HCC study”) $197,000

12.

(Bayer, Industry Sponsored) Martin (PI) - 3/1/2009-6/1/2011 HCC Non-Interventional Study –GIDEON $65,000

13.

(Investigator Initiated) Martin (PI) - 4/18/2009-12/31/2011 Clinical Evaluation of Neoadjuvant Gemcitabine, Docetaxel, and capecitabine with Concurrent Radiation for Patients with Borderline/ Locally Advanced Pancreatic Carcinoma (Unfunded)

14.

(ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011 A phase II study of preoperative and postoperative gemcitabine and erlotinib for patients with operable pancreatic adenocarcinoma.

15.

(ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011 A phase II study of neoadjuvant therapy with cisplatin, docetael, panitumunab plus radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus.

16.

(Industry Sponsored, Investigator Initiated) Martin (PI) - 6/1/2008-12/31/2010 Clinical Evaluation of Polyflex Stenting in Esophageal Cancer patients Undergoing Chemotherapy and/or Radiation therapy $118,000

17.

(Industry Sponsored, Investigator Initiated) Martin (PI) - 6/1/2008-6/30/2010 FDA: IND Submission (Martin) #08.0119 (NCT00955097) Evaluation of intra-operative ultrasound contrast enhancement in the evaluation of liver Tumors (Unfunded)

18.

(Industry Sponsored, Investigator Initiated) Martin (PI) - 3/1/2008-12/31/2010 FDA IND Submission (Martin) #CR012460, EPOSUR4005 A prospective, randomized, double blinded control study or procrit vs placebo to determine efficacy in pre-operative patients undergoing major surgical oncology procedures. $129,000

19.

(Industry Sponsored) Martin (PI) - 10/11/2008-12/31/2010 19

CURRICULUM VITAE

January 5th, 2014

Selective Internal Radiation Therapy (SIRT) + 5-Fluorouracil, Leucovorin and OXaliplatin [FOLFOX6m] vs. FOLFOX6m alone $197,588 20.

(Investigator Initiated) Martin (PI) - 5/1/2009-12/31/2010 Effect of Reinforced Staple Line on Leak Rate in Distal Pancreatectomy (Unfunded)

21.

(Investigator Initiated) Martin (PI) - 4/3/2004- 8/2012 TheraSphere Hepatocellular Humanitarian Device Exemption Programs and Compassionate Use Metastatic to Liver Program (Unfunded)

22.

(Investigator Initiated) Martin (PI) - 12/1/2002-8/30/2003 Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy.

23.

(Investigator Initiated) Martin (PI) - 7/1/2006-6/30/2009 Norton Healthcare Community Trust Fund. Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical Oncology Operations. $150,000.

24.

(Vivant Medical, Investigator Initiated) Martin (PI) - 1/4/2004-10/31/2004 A Phase II study of Microwave Hepatic Ablation: Safety and Efficacy. $50,000

25.

(Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2004-10/15/2004 A Phase 2, Randomized, Double-Blind Study of the Safety and Efficacy of Topical rhThrombin in Subjects Undergoing Partial Hepatectomy. $110,000

26.

(Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2006-6/15/2006 A Phase 3, Randomized, Double-Blind, Controlled Study of the Safety and Efficacy of Topical rhThrombin (1000 U/mL) in Surgical Hemostasis. $188,000

27.

(University of Calgary, Investigator Initiated) Martin (PI) - 7/9/2007-6/30/2008 Randomized Control Trial Comparing the Effectiveness of a Web Based Journal Club to a Standard Journal Club Format to Teach Critical Appraisal Skills. $2000 The American Surgeon 2005-Present Editorial Boards:

20

CURRICULUM VITAE

January 5th, 2014

Annals of Surgical Oncology 2009-Present World Journal of Gastroenterology 2009-Present Contributing Associate Editor-in-Chief2011-Present International Journal of Surgical Oncology2009-Present HPB 2010-Present The American Journal of Surgery 2012- Present Journal of Gastrointestinal Surgery 2011-Present Invited Reviewer:

American Journal of Surgery 1998-2005 Annals of Surgery 2008 Annals of Surgical Oncology 2005-Present BMC Cancer 2006 Cancer Control: Journal of the Moffitt Cancer 2005 Center Clinical Chemistry and Laboratory Medicine 2005 Clinical Cancer Research 2008 Cancer 2008 Critical Reviews in Oncology/Hematology2006 Digestive and Liver Disease 2007 European Journal of Surgical Oncology 2006-Present Endocrine Related Cancer 2006 Future Oncology 2006 International Journal of Cancer 2006 Journal of the American College of Surgeons 2002-Present Journal of Surgical Research 2003 Journal of Clinical Oncology 2006 Medical Science Monitor 2005-2006 Mutation Research 2009 Southern Medical Journal 2002 Surgery 2006-Present The American Surgeon 2004-Present World Journal of Surgical Oncology 2007-Present

Peer-Reviewed Publications: 1.

Spain DA, Martin RCG, Carrillo EH, Polk HC Jr. Twelfth rib resection: Preferred therapy for subphrenic abscess in selected surgical patients. Arch Surg 132:1203-1206, 1997.

2.

Seligson D, Howard PA, Martin RCG. Difficulty in removal of certain intramedullary nails. Clin Orthop 340:202-206, 1997. 21

CURRICULUM VITAE

January 5th, 2014

3.

Flynn MB, Amin EA, Martin RCG. Mobile mammography screening: The James Graham Brown Cancer Center three year experience. J KY Med Assoc 96:17-20, 1998.

4.

Flynn MB, Greenwell D, Martin RCG. Value of preoperative localization studies prior to initial neck exploration for hyperparathyroidism. J KY Med Assoc 97:255-260, 1999.

5.

Martin RCG, Flynn MB. Initial neck exploration for untreated hyperparathyroidism. Am Surg 66:269-272, 2000.

6.

Martin RCG, Edwards MJ, Cawte TG, Sewell CL, McMasters KM. Basosquamous carcinoma: Analysis of prognostic factors influencing recurrence. Cancer 88:1365-1369, 2000.

7.

Martin RCG, Stutz JP. Multiple granular cell tumors of the gallbladder and biliary tree: Literature review and case report. Gastrointest Endosc 51:238-240, 2000.

8.

Martin RCG, Edwards MJ, McMasters KM. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis. Oncol Rep 7:413-419, 2000.

9.

Martin RCG, McMasters KM, Wong SL, Tuttle TM, Edwards MJ. Optimal gamma probe detection of sentinel lymph nodes in breast cancer: Results of a nationwide multi-institutional study. Surgery 128:1-6, 2000.

10.

Reed DS, Martin RCG, Vitale GJ. Bile duct carcinoma: Trends in treatment in the nineties. Am Surg 66:711-715, 2000.

11.

Flynn MB, Greenwell D, Martin RCG, Cerrito PB. Safety and effectiveness of methylene blue infusion for intraoperative identification of parathyroid glands. J Surg Invest 3:227-233, 2001.

12.

Martin RCG, McMasters KM. Presentation of histoplasmosis as an isolated liver lesion: Case report and review. Am Surg 5:430-431, 2001.

13.

Klodell CT, Martin RCG, Allen JW, Polk HC. Value of an advanced surgical technology experience in the basic education of general surgical residents. Bulletin American College of Surgeons 86:11-15, 2001.

14.

Martin RCG, DeRossis AM, Fey J, Yeung H, Yeh SDJ, Akhurst T, Heerdt AS, Petrek J, VanZee KJ, Montgomery LL, Borgen PI, Cody HS. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 130:432-438, 2001. 22

CURRICULUM VITAE

January 5th, 2014

15.

McMasters KM, Wong SL, Martin RCG, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: Results of a multi-institutional study. Ann Surg 233:676-687, 2001.

16.

Martin RCG, Fong Y, Dematteo RP, Blumgart LH, Jarnagin WR. Peritoneal washings are not predictive of advanced stage in hilar cholangiocarcinoma. J Am Coll Surg 193:620-625, 2001.

17.

Martin RCG, Fey J, Borgen PI, Cody HS. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 8:592-597, 2001.

18.

Martin RCG, Jarnagin WR. Randomized Clinical Trials in Hepatocellular Carcinoma and Biliary Cancer. Surg Oncol Clin North Am, Jan, 11:193-205, 2002.

19.

Martin RCG, Klimstra D, Brennan MF, Conlon KC. Solid-pseudo papillary tumors of the pancreas: A surgical enigma. Ann Surg Oncol 9:35-40, 2002.

20.

Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ, McMasters KM. Cost comparison of endoscopic stenting versus surgical treatment for unresectable cholangiocarcinoma. Surg Endosc 16:667-670, 2002.

21.

Martin RCG, Spain DA, Richardson JD. Do facial fractures protect the brain or are they a marker for severe head injury? Am Surg 68:478-481, 2002.

22.

Martin RCG, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally advanced gastric cancer: Is it worth the risk of multi-organ resection? J Am Coll Surg, 194(5), 568-577, 2002.

23.

Martin RCG, Brennan MF, Jaques DP. The quality of complication reporting in the surgical literature. Ann Surg 235:803-813, 2002.

24.

McMasters KM, Chao C, Wong SL, Martin RCG, Edwards MJ. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95:15-20, 2002.

25.

Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RCG, McMasters KM. C-terminal deletion mutant p21 (WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Cancer Gene Ther 9:453-463, 2002.

26.

Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: Increased survival vs increased morbidity? Ann Surg 236:159-165, 2002.

27.

Martin RCG, Klimstra D, Jarnagin WR, Blumgart LH. Hepatic intraductal oncocytic 23

CURRICULUM VITAE

January 5th, 2014

papillary neoplasm. Cancer 95: 2180-2187, 2002. 28.

Martin RCG, Jarnagin WR. Peripheral/Intrahepatic Cholangiocarcinoma: Current Management. Minerva Chirurgica 58, 469-478, 2003.

29.

Martin RCG, Antonescu C, Brennan MF. Adult soft tissue Ewing sarcoma and primitive neuroectodermal tumors: Is age an adverse predictor of survival? Arch Surg 138: 281-285, 2003.

30.

Martin RCG, Jarnagin W, Fong Y, Blumgart L, DeMatteo RP.The Use of Fresh Frozen Plasma After Major Hepatic Resection For Colorectal Metastasis, Is there a standard for transfusion? J Am Coll Surg, 196, 402-409, 2003.

31.

Martin RCG, Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart LH. Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? J Am Coll Surg, 197, 233-242, 2003.

32.

Martin RC, Polk HC, Jr., Jaques DP. Does additional surgical training increase participation in randomized controlled trials? Am J Surg 2003; 185:239-243.

33.

Chao C, Abel T, Martin RCG, McMasters KM. Intraoperative Frozen Section of Sentinel Nodes: A Formal Decision Analysis. Am Surg, 2004;70(3):215-220.

34.

D'Angelica M, Martin RCG, Jarnagin WR, Fong Y, DeMatteo RP, Blumgart LH. Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg 2004;198(4):570-576.

35.

Palmer L, Martin RCG, Hein DW. Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and health care disparities. Pharmacogenetics. 2004; 5(3):319-329.

36.

Chagpar A, Pilavas J, Chao C, Martin RCG, McMasters KM. Sentinel lymph node biopsy for breast cancer: addressing the controversies. Cancer Therapy 2003, 1:223-232.

37.

Chagpar A, Martin RCG, Chao C, Wong, SL, Edwards MJ, Tuttle T, McMasters KM. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004; 139(6):614-618.

38.

Chao C, Martin RCG, Ross MI, Reintgen DS, Edwards MJ, McMasters KM. Correlation Between Prognostic Factors and Increasing Age in Melanoma. Ann Surg Onc 2004, 11(3), 259-264. 24

CURRICULUM VITAE

January 5th, 2014

39.

Chagpar A, Martin RCG, Hagendoorn LJ, Chao C, McMasters KM. Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg 188(4), 399-402, 2004.

40.

D'Angelica M, Martin RC, Jarnagin WR et al. Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg 2004; 198:570-576.

41.

Hughes KH, Kelty S, Martin RCG. Hepatoid Carcinoma of the Pancreas. American Surgeon 70, 130-133, 2004.

42.

Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W, Rothman N, Hein DW. Method for Determination of (-102C>T) Single Nucleotide Polymorphism in the Human Manganese Superoxide Dismutase Promoter. BMC Genetics 5:33, 2004.

43.

Edwards MJ, Broadwater R, Tafra L, Jarowenki D, Mabry C, Beitsch P, Whitworth P, Martin RCG, Oetting L. Progressive adoption of cryoablation therapy for breast fibroadenoma in community practice. Am J Surg 188, 221-224, 2004.

44.

Martin RCG. Intraoperative Magnetic Resonance Imaging Ablation of Hepatic Tumors: A Surgeon’s Perspective. Am J Surg 189, 388-394, 2005.

45.

Martin RCG, Edwards MJ, McMasters KM. Morbidity of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy in the Management of Colorectal Cancer Metastatic to the Liver. Am J Surg 188(6), 714-721, 2004

46.

Sholar A, Martin RCG, McMasters KM. Popliteal Lymph Node Dissection. Ann Surg Onc 12(2), 189-193,2005.

47.

Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W, Rothman N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102) Genotypes and Risk of Gastric Cancer. J of Surg Res 124, 92-97, 2005.

48.

Martin RCG, D’Angelica M, Blumgart LH. Papillary Low Grade Neuroendocrine Tumor of the Pancreas with Pancreatic Duct Dilation. Archives of Surgery 140(3), 311-312, 2005.

49.

Li Yan, Wo J, Su R, Ray MB, Jones W, Martin RCG. Esophageal Injury with a Novel External Esophageal Perfusion. J Surg Res 129 (1), 107-113, 2005.

50.

Martin RCG, Chagpar A, Scoggins CS, Edwards MJ, Hagendoorn L, Stromberg AJ, McMasters KM. Clinicopathologic Factors Associated With False Negative Sentinel Lymph Node Biopsy in Breast Cancer. Ann Surg 241(6), 1005-10012, 2005. 25

CURRICULUM VITAE

January 5th, 2014

51.

Martin RCG, Kehdy FJ, Allen JW. Formal Training in Advanced Surgical Technologies Enhances the Surgical Residency. Am J Surg 190(2), 244-248, 2005. \

52.

Chagpar AB, Martin RCG, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM. Factors Predicting Failure to Identify a Sentinel Lymph Node in Breast Cancer. Surgery 138, 56-63, 2005.

53.

Scoggins CR, Chagpar AB, Martin RCG, McMasters KM. Should sentinel lymph-node biopsy be used for staging melanoma and breast cancers? Nature Clinical Practice Oncology 2(9), 448-455, 2005.

54.

Conn CA, McMasters KM, Edwards MJ, Martin RCG. Acceptance of Sentinel Lymph Node Biopsy of the Breast by All General Surgeons in Kentucky. The Breast Journal 11(4), 231-235, 2005.

55.

Herrman B, Li Y, Ray M, Wo J, Martin RCG. Association of Manganese Superoxide Dismutase Expression with Progression of Carcinogenesis in Barrett’s Esophagus. Archives of Surgery 140(12), 1204-1209, 2005.

56.

Martin RCG, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters KMM. Is Incisional Biopsy of Melanoma Harmful? Am J Surg 190(6), 913-917, 2005.

57.

Hutchinson JR, Chagpar AB, Scoggins CR, Martin RCG, McMaster KM. Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg 2005; 190:903-906.

58.

Martin RCG, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Ann Surg Onc 12 (12) 1017-1024, 2005.

59.

Martin RCG, Scoggins, CR, McMasters KMM. A Phase II Study of Radiofrequency Ablation of Unresectable Metastatic Colorectal Cancer with Hepatic Arterial Infusion Pump Chemotherapy. J Surg Onc 2006; 93(5):387-393.

60.

Martin RCG, Augenstein VA, Scoggins CR, McMasters, KM. The Quality of Survival Reporting in Chemotherapy and Surgery Trials in Metastatic Colorectal Cancer. Cancer 106 (6) 1389-1394, 2006.

61.

Chagpar AB, Scoggins CR, Sahoo S, Martin RCG, McMasters KM. Biopsy type does not influence sentinel lymph node status. Am J Surg 2005; 190:551-556. 26

CURRICULUM VITAE

January 5th, 2014

62.

Chagpar AB, Kehdy F, Scoggins CR, Martin RCG, McMasters KM. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005; 190:557-562.

63.

Li Y, Ray M, Koopman J, Wo JM, Martin RC Cycloxygenase -2 and Epithelial Growth Factor Receptor up-Regulation during Progression of Barrett's Esophagus to Adenocarcinoma. World J Gastroenterol, 12(6) 928-934, 2006.

64.

Martin RCG, Studts JL, McGuffin SA, Roetzer LM, Abell TA, McMasters KM. Method of Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-making in Metastatic Colorectal Cancer. Ann Surg Onc 13(1), 86-95, 2006.

65.

Chagpar AB, Studts JL, Scoggins CR, Martin RCG, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, McMasters KM. Factors associated with surgical options for breast carcinoma. Cancer 2006; 106:1462-1466.

66.

Li Y, Ellis SE, Ray M, Wo J, Martin RC. A Novel External Esophageal Perfusion Model for Reflux Esophageal Injury. Digestive Diseases and Sciences, 51(3), 527-532, 2006.

67.

Chagpar AB, Scoggins CR, Martin RC, Cook EF, McCurry T, Mizaguchi N, Paris KJ, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters, KM. Predicting patients at low probability of requiring post-mastectomy radiation therapy”. Ann of Surg Onc, 2006:14:670-677.

68.

Martin RCG, Husheck Steven, Scoggins CR, McMasters KM. Intraoperative Magnetic Resonance Imaging Ablation of Hepatic Tumors. Surgical Endoscopy 2006; 20(10): 15361542.

69.

Martin RCG. Adjuvant Treatment of Stage II Colon Cancer: Is there a true no chemotherapy group? Editorial Ann Surg Onc 13(6), 766-767, 2006.

70.

D'Angelica M, Maddineni S, Fong Y, Martin RCG, Cohen MS, Ben-Porat L, Gonen M, DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg 2006; 30:410-418.

71.

Martin RCG. Hepatic Tumor Ablation: Cryo versus Radiofrequency, which is better? Editorial Am Surg, 72(5) 391-392, 2006.

72.

Lewis A, Martin RCG. The Treatment of Hepatic Metastases in Colorectal Carcinoma. American Surgeon 2006; 72(6): 466-473. 27

CURRICULUM VITAE

January 5th, 2014

73.

Li Y, Wo J, Su R, Ray M, Martin RCG. Morphological Transformation in Esophageal Submucosa by Bone Marrow Cells Esophageal Implantation under External Esophageal Perfusion. Stem Cells and Development, Oct, 15 (5):697-705 2006.

74.

Eid S, Stromberg AJ, Ames S, Ellis S, McMasters KM, Martin RCG. Assessment of symptom experience in patients undergoing hepatic resection or ablation. Cancer, 107(11), 2715-2720, 2006.

75.

Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin RCG, Abrecht J, MaMasters KM Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006; 24:2849-2857.

76.

Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin RCG, Abrecht J, McMasters KM Gender-related differences in outcome for melanoma patients. Ann Surg 2006; 243:693-700.

77.

Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Prediction of sentinel lymph nodeonly disease in women with invasive breast cancer. Am J Surg 2006; 192:882-887.

78.

Martin RCG, Ahn J, Nowell S, Hein DW, Doll M, Martini B, Ambrosone CB. Association between Manganese Superoxide Dismutase Promoter Gene Polymorphism and Breast Cancer Survival. Breast Cancer Research; 8(4), R45- 2006.

79.

Chagpar AB, McMasters KM, Martin RC, Scoggins CR. Determinants of early distant metastatic disease in elderly patients with breast cancer. Am J Surg 2006; 192:317-321.

80.

Wells G, Martin RC, McMasters KM, Scoggins CR. Soft tissue sarcoma of the extremity and trunk: issues for the general surgeon. Am Surg 2006; 72:665-671.

81.

Martin RCG. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement. Ann Surg Onc 14 (1) 128-133, 2007.

82.

Martin RC, Eid S, Scoggins CR. Health-related quality of life: return to baseline after major and minor liver resection. Surgery 2007; 142:676-684.

83.

Li Y., Wo J., Su R, Ray M, Martin RCG. Loss of Manganese Superoxide Dismutase Expression and Activity in Rat Esophagus with External Esophageal Perfusion. Surgery 141(3) 359-367, 2007.

84.

Li Y., Wo J., Su R, Ray M, Martin RCG. Alterations in Manganese Superoxide Dismutase 28

CURRICULUM VITAE

January 5th, 2014

expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Onc 14(7) 2045-2055, 2007. 85.

Martin RCG, Scoggins CR, McMasters KM. Microwave Hepatic Ablation: Safety and Efficacy. J Surg Oncol 2007; 96:481-486.

86.

Martin RCG, Loehle J, Scoggins CR, McMasters KM. Kentucky Hepatoma: epidemiological variant or same problem different region? Arch Surg 142(5), 431-436 2007.

87.

Woodall CE, Scoggins CR, Loehle J, Ravindra KV, McMasters KM, Martin RCG. Hepatic Imaging Characteristics Predict Overall Survival in Hepatocellular Carcinoma. Ann Surg Onc 2007; 14(10):2824-2830.

88.

Iannitti D., Martin RCG, Simon C, Newcomb W, McMasters KM, Dupuy, D. Hepatic Tumor Ablation with Clustered Microwave Antennae: The US Phase II Trial. HPB 9(2); 120124, 2007.

89.

Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007 Nov;143(1):164-168.

90.

Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2007; 14:670677.

91.

Weber R, Jabboru N, Martin RCG. Anemia and Transfusions in Patients Undergoing Surgery for Cancer. Ann Surg Onc 2008; 15(1):34-45.

92.

Chagpar AB, Scoggins CR, Martin RC, Carlson DJ, Laidlely AL, Eid SE, McGlothin TQ, McMasters KM. Are 3 sentinel nodes sufficient? Arch Surg 2007 May;142(5):456-9; discussion 459-60.

93.

Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RCG, Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN, Abdalla EK, Curley SA, Choti MA, Elias D. Liver-Directed Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis. Ann Surg Onc June 2007; 14(10):2807-2816.

94.

Helm CW, Toler CR, Martin RCG, Gordinier ME, Parker LP, Metzinger DS, Edwards RP. Cytoreduction and Intraperitoneal Heated Chemotherapy (IPHC) for the Treatment of Endometrial Carcinoma Recurrent Within the Peritoneal Cavity. Int J. Gynecol Cancer 2007; 29

CURRICULUM VITAE

January 5th, 2014

17(1):204-209. 95.

Helm CW, Randall-Whitis L, Martin RCG, Metzinger D, Gordinier M, Parker L, Edwards R. Hyperthermic Intraperitoneal Chemotherapy In Conjunction With Surgery For The Treatment Of Recurrent Ovarian Carcinoma. Gynecologic Oncology 2007; 105(1):90-96.

96.

Li Y, Martin RCG. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Dis of Esophagus 2007; 20(5):372-378

97.

Martin RCG Invited commentary for Lancet Oncology 2007 of manuscript: Camacho et al The Lancet Oncology: http://oncology.thelancet.com

98.

Martin RCG, Liu Q, Wo JM, Ray MB, Li Y. Chemoprevention of Carcinogenic Progression to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation. Clinical Cancer Research 2007;13(17):5176-5182.

99.

Chagpar AB, Scoggins CR, Martin RC, Sahoo S, Carlson DJ, Laidley AL, El-Eid SE, McMasters KM. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J 2007; 13:233-237.

100.

Chagpar AB, McMasters KM, Saul J, Nurko J, Martin RC, Scoggins CR, Edwards MJ. Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg. 2007 Jun;73(6):555-60.

101.

Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Hepatic Malignant Epithelioid Hemangioendothelioma: A case report and review of the literature. Am Surg 2008; 74(1):64-68.

102.

Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Adequate Lymphadenectomy Results in Accurate Nodal Staging without an Increase in Morbidity in Patients with Gastric Adenocarcinoma. Am J Surg 2008; 196(3) 413-17.

103.

Chagpar AB, McMasters KM, Scoggins CR, Martin RC, Thoene C, Edwards MJ. The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg 2008 June; 195(6):793-8.

104.

Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR. Effect of Multiple-Nodal Basin Drainage on Cutaneous Melanoma. Arch Surg 2008 July;143(7):632-7.

30

CURRICULUM VITAE

January 5th, 2014

105.

Landry CS, Scoggins CR, McMasters KM, Martin RCG. Management of Hepatic Metastasis of Gastrointestinal Carcinoid Tumors. J Surg Oncol 2008; 97(3): 253-258.

106.

Li Y, Woodall CE, Wo JM, Zheng H, Ng CK, Ray MB, Martin RCG. The use of dynamic positron emission tomography imaging for the evaluation of the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest 2008 26(3): 278-285.

107.

Landry CS, McMasters KM, Scoggins CR, Martin RCG. Proposed Staging System for Gastrointestinal Carcinoid Tumors. Am Surg 2008 74(5): 418-422.

108.

Martin RCG, Barker DF, Doll MA, Pine S, Mechanic L, Bowman ED, Harris CC, Hein DW. Manganese Superoxide Dismutase Gene Coding Region Polymorphisms Lack Clinical Incidence in General Population. DNA and Cell Biol. 2008 27(6): 321-323.

109.

Landry CS, McMasters KM, Scoggins CR, Woodall CE, Martin RCG. Analysis of 900 Appendiceal Carcinoid Tumors with a Proposal for a Staging System. Arch Surg 2008 143(7): 664-670. G19

110.

Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents in Esophageal Strictures: Less Cost and More Efficiency. Ann Thor Surg 2008, 86(2) 436440.

111.

Woodall CE, Scoggins CR, Martin RCG. Yttrium-90 use in unresectable primary and metastatic liver tumors. US Gastroenterology Review, June 2008.

112.

Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt CM, Merchant N, Parikh A, Martin RCG; Scoggins C, Ahmad S, Kim HJ, Park J, Johnston F, Strouch M, Menze A, Rymer J; McClaine R, Strasberg S, Talamonti M, Staley C, McMasters K, Lowy A, Byrd-Sellers J, Wood W, Hawkins W. Left-sided pancreatectomy: a multicenter analysis of open and laparoscopic approaches. Annals of Surgery 2008; 248(3):438-446.

113.

Deneve J, Pawlik T, Cunningham S, Clary B, Reddy S, Scoggins C, Martin RCG, D'Angelica M, Staley C, Choti M, Jarnagin, W, Schulick R, Kooby DA. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2008.

114.

Landry CS, Brock, G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging System for Small Bowel Carcinoid Tumors Based on an analysis of 6,380 patients. Am J Surg 196(6) 896-903, 2008.

115.

Landry CS, McMasters KM, Scoggins CR, Martin RCG A proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients. Ann Surg Onc 16(1), 5160, 2009. 31

CURRICULUM VITAE

January 5th, 2014

116.

Landry CS, Brock G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging System for Rectal Carcinoid Tumors based on an Analysis of 4701 patients. Surgery 144(3) 460-466, 2008.

117.

Reuter NP, MacGregor JM, Woodall CE, Sticca RP, Helm CW, Scoggins CR, McMasters KM, Martin RCG. Preoperative performance status predicts outcomes following hyperthermic intraperitoneal chemotherapy. Am J Surg 2008 December Vol 196(6): 909-14.

118.

Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RCG. Proposed Staging System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients. J Am Coll Surg. 207(6) Dec 2008:874-881.

119.

Woodall CE, Duvall R, Scoggins CR, McMasters KM, Martin RCG. Esophageal carcinoma histology affects peri-operative morbidity following open esophagogastrectomy. J Onc 2008: 1-7

120.

Martin RC, Barker DF, Doll MA, Oine SR, Mechanic L, Bowman ED, Haris CC, Hein DW. Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population. DNA Cell Biol 2008; 27(6):321-323.

121.

Martin RCG, Scoggins CR, Egnatashvili V, Staley C, McMasters KM, Kooby DA. Arterial and Venous Resection for Pancreatic Adenocarcinoma: Operative and Long-term Outcomes. Arch Surg 2009; 2:154-159.

122.

Martin RCG, Li Y, Liu Q, Jensen NS, Barker DF, Doll MA, Hein DW. Manganese Superoxide Dismutase V16A Single Nucleotide Polymorphism in the Mitochondrial Targeting Sequence is Associated with Reduced Enzymatic Activity in Cryopreserved Human Hepatocytes. DNA Cell Biol, 28(1), 3-7, 2009.

123.

Shelgikar CS, Loehle J, Scoggins CR, McMasters KM, Martin RCG. Empiric Antibiotics for Transarterial Embolization in Hepatocellular Carcinoma: Indicated? J Surg Res 151(1); 121-124: 2009

124.

Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents in Esophageal Cancer Care: Optimal Pre-, Peri-, and Post-operative Care. Surgical Endoscopy 2009, 23 (3):615-620.

125.

Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Radiofrequency ablation versus resection for hepatic colorectal metastasis therapeutically equivalent? J GI Surg 2009 Mar: 13(3): 486-91.

32

CURRICULUM VITAE

January 5th, 2014

126.

Merchant NB, Rymer J, Koehler EA, Ayers GD, Castellanos J, Kooby DA, Weber SH, Cho CS, Schmidt CM, Nakeeb A, Matos JM, Scoggins CR, Martin RC, Kim HJ, Ahmad SA, Chu CK, McCaine R. Bednarski BK, Staley CA, Sharp K, Parikh AA. Adjuvant Chemoradiation Therapy for Pancreatic Adenocarcinoma: Who Really Benefits? Surg 2009 May; 208(5):829-38.

127.

Weber SM, Cho CS, Merchant N, Pinchot S. Rettammel R, Nakeeb A, Bentrem D, Parikh A, Mazo AE, Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins W, Max Schmidt C, Kooby DA. Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009 Oct;16(10):2825-33.

128.

Byam J, Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation? Ann Surg Oncol 2009 Nov 3:7:80

129.

Li Y, Wo J, Liu Q, Li X, Martin RCG. Chemoprotective Effects of Curcuma Aromatica on Esophageal Carcinogenesis. Ann Surg Onc 2009; 2:515-523.

130.

Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM, Martin RCG. Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases. Ann Surg Onc 16(1), 35-41, 2009

131.

Woodall CE, Scoggins CR, Ravindra K, Ellis SF, Tatum CM, Hahl MJ, Hiken JN, Jones BC, McMasters KM, Martin RCG. Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis? J Am Coll Surg 2009 Mar; 208(3): 375-382

132.

Martin RCG, Augenstein V, Reuter NR, Scoggins CR, McMasters KM. Simultaneous vs. Staged Resection for Synchronous Colorectal Cancer Liver Metastases. J Am Coll Surg 2009 May; 208(5):842-850

133.

Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. Nutritional Support with Endoluminal Stenting during Neoadjuvant Therapy for Esophageal Malignancy. Ann Surg Oncol 2009; 16:31661-3168.

134.

Woodall CW, Li Y, Liu Q, Reuter N, Martin RCG. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anticancer Drugs 20 (6): 437-443 2009.

135.

Woodall CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RCG. An Evaluation of 2,537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging 33

CURRICULUM VITAE

January 5th, 2014

System. Arch Surg 144(7): 670-678, 2009 136.

Woodall CE, Martin RC, Stromberg AJ, Ginter B, Burton A, Ross MI, Edwards MJ, McMasters KM, Scoggins CR. Do melanoma patients from southern climates have a worse outcome than those form northern climates? Am Surg 2009 Aug; 75(8):687-92; discussion 692.

137.

Reuter NP, Martin RCG. Microwave energy as a pre-coagulative device to assist in hepatic resection. Ann Surg Onc 16: 3057-3063, 2009

138.

Bower M, Martin RCG. Nutritional Management during Neoadjuvant Therapy for Esophageal Cancer. J Surg Onc 2009 July Vol 100(1): 82-87

139.

Martin RCG, Robbins K, Tomalty D, O’Hara R, Bosnjakovik Padr R, P, Derner M, Rocek M, Slauf F, Scupchenko A, and Tatum C. Transarterial chemoembolization (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: An Interim Report. World J of Surg Onc 2009, 7:80:1-12.

140.

Jones, WF, Martin RCG. Confronting the barriers to colorectal cancer screening and treatment. J KY Med Assoc, 107(3): 86-87, 2009

141.

Martin RCG, Joshi J, Robbins K, Tomalty D, O’Hara R. Tatum C. Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug Eluting Beads: MultiInstitutional Study. J of Oncology 12(5), 539-545, 2009

142.

Schiffman SC, Woodall CE, Kooby DA, Martin RC, Staley CA, Egnatashvili V, McMasters KM, Scoggins CR. Factors associated with recurrence following hepatectomy for large hepatocellular carcinoma: A multicenter analysis. J Surg Oncol 2009; 101(2);105-11.

143.

Martin RC, Scoggins CR, McMasters KM. Safety and Efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010 Jan;17(1):171-8

144.

Li Y, Reuter NP, Li X, Liu Q, Zhang J, Martin RCG. Colocalization of MnSOD expression in response to oxidative stress. Mol Carcinog 2010 Jan;49(1):44-53

145.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Beitsch PD, McMasters KM. Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients. Ann Surg Oncol 2010 17:709-717.

146.

Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters KM, Martin RCG. Safety of Hepatic Resection in metastatic disease to the liver after Yttrium-90 therapy. J Surg Res

34

CURRICULUM VITAE

January 5th, 2014

Available online 12 June 2009. 147.

Martin RCG, Li Y, Liu Q, Barker DF, Doll MA, Hein DW. MnSOD genotype and the expression effects on Lung Cancer Initiation and Biology. Cancer Investigation 1-7, 2009 ISSN: 0735-7907 print / 1532-4192 online

148.

Carter S, Martin RCG. Drug Eluting Bead Therapy in Primary and Metastatic Disease to the Liver. HPB 11(7), 541-550, 2009

149.

Benns M, Woodall C, Scoggins CR, McMasters KM, Martin RCG. The Impact of Obesity on Outcomes Following Pancreatectomy for Malignancy. Ann Surg Onc 16((), 2565-2569, 2009.

150.

Bower MR, Metzger T, Robbins K, Tomalty D, Andrasina T, Tatum C, Scoggins CR, McMasters KM, Martin RCG. Surgical Downstaging and Neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug eluting beads: a multi-institutional study. HPB 12(1); 31-36, 2010.

151.

Martin RCG, McMasters KM, Scoggins CR. Laparoscopic Hepatic Lobectomy: Advantages Of A Minimally Invasive Approach. JACS 210(5) 627-631, 2010.

152.

Bower MR, Aiyer HA, Martin RCG. Chemoprotective Effects of Curcumin in Esophageal Epithelial Cells Exposed to Bile Acids. WJ Gastroenterology 16(33): 4151-4158, 2010.

153.

V. J. Picozzi; R. A. Abrams; P. A. Decker; W. Traverso; E. M. O'Reilly; E. Greeno; R.C. Martin; L. S. Wilfong; M. L. Rothenberg; M. C. Posner; P. W. T. Pisters; for the American College of Surgeons Oncology Group. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Annals of Oncology 2010; doi: 10.1093/annonc

154.

Brown R, Bower M, Martin RCG. Hepatic Resection for Colorectal Liver Metastases Surgical Clinics of North America (SCNA) Liver Surgery, 90(4): 839-852, 2010.

155.

Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. The role of esophageal stents in the nutritional support of patients with esophageal malignancy. Nutrition in Clinical Practice June 2010 Vol 25(3); 244-249

156.

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CRl. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 Mar 15, 116(6) pp 1535-44. 35

CURRICULUM VITAE

January 5th, 2014

157.

Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR, McMasters KM, Martin RCG. Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg Available online Sept 28

158.

Augenstein VA, Reuter NP, Bower MR, McMasters KM, Scoggins CR, Martin RCG. Routine intra-operative biliary cultures during pancreaticoduodenectomy: A guide to avoid postoperative complications. J Surg Onc 2010 Oct 1; 102(5); 478-81.

159.

Martin RCG, Howard J, Tomalty D, Robbins K, Padr R, Bosnjakovic PM, Tatum C. Toxicity of Irinotecan Eluting Beads in the treatment of Hepatic Malignancies: Results of Multi-Institutional Registry. CVIR 2010; 33(5) 960-66.

160.

Bowling, J. T.; Reuter, N. P.; Martin, R. C.G.; McMasters, K. M.; Tatum, C.; Scoggins, C. R. Prior Biliary Tree Instrumentation Does Not Preclude Hepatic Arterial Therapy for Malignancy. Am. Surg 2010; 76, 618-621.

161.

Brown R, Hagendoorn L, Stromberg AJ, Scoggins CR, McMasters KM, Martin RCG. Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest Radiography. Surgery 2010 Vol 148(4) 711-717.

162.

Schiffman SC, Li Y, Dryden GW, Li X, Martin RCG. Image analysis by mini-endoscopy in rats after esophagoduodenal anastomosis. Surg Endo 24 (11) 2835-2841, 2010.

36

CURRICULUM VITAE

January 5th, 2014

163.

Schiffman SC, Li Y, Li X, Aiyer HA, Martin RCG. The Resistance if Esophageal Cancer Cells to Bile Salt Insult Is Associated with Manganese Superoxide Dismutase. J Surg Res 2010. Vol 158(2) Feb 2010, page 2.

164.

Aiyer HS, Li Y, Losso JN, Gao C, Schiffman SC, Slone SP, and Martin RC: Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma. Nutr Cancer 2011, 63:1256-1262

165.

Aiyer HS, Li Y, Harper N, Myers SR, and Martin RC: Molecular changes in the esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of bile-acid reflux. Inhal Toxicol 2011, 23:304-311

166.

Aiyer HS, Li Y, Liu QH, Reuter N, and Martin RC: Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats. Nutrition 2011, 27:182-187.

167.

Aiyer, HS, Li Y, and Martin RC: Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract. J Surg Res 2011, 168:42-48

168.

Bower M, Sherwood L, Li Y, and Martin R: Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 2011, 104:22-28

169.

Bower M, Ellis SF, Scoggins CR, McMasters KM, and Martin RC: Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011, 18:166-173

170.

Brown RE, St Hill CR, Greene QJ, Farmer RW, Reuter NP, Callendar GG, Martin RC, McMasters KM, and Scoggins CR: Impact of histology on survival in retroperitoneal sarcomas. Am J Surg 2011, 202:748-752

171. Brown RE, Abbas AE, Ellis S, Williams S, Scoggins CR, McMasters KM, and Martin RC: A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011, 212:582588 172. Brown RE, Gibler KM, Metzger T, Trofimov I, Krebs H, Romero FD, Scoggins CR, McMasters KM, and Martin RC: Imaged guided transarterial chemoembolization with drugeluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry. Am Surg 2011, 77:93-98 173. Brown RE, Martin RC, and Scoggins CR: Ablative therapies for colorectal liver metastases. Surg Oncol Clin N Am 2011, 20:259-71, vii 37

CURRICULUM VITAE

January 5th, 2014

174.

Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ, Tatum C, and Martin RC: Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 2011, 13:91-95

175.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC, McMasters KM, Scoggins CR, and Callender GG: Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg 2011, 77:10091013

176.

Burton AL, Roach BA, Mays MP, Chen AF, Ginter BA, Vierling AM, Scoggins CR, Martin RC, Stromberg AJ, Hagendoorn L, and McMasters KM: Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg 2011, 77:188-192

177.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC, and McMasters KM: Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011, 202:659664

178.

Cannon RM, Martin RC, Callender GG, McMasters KM, and Scoggins CR: Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011, 104:804-808

179.

Chagpar RB, Martin RC, Ahmad SA, Kim HJ, Rupp C, Weber S, Ebelhar A, Gilbert J, Brinkman A, Winslow E, Cho CS, Kooby D, Chu CK, Staley CA, McMasters KM, and Scoggins CR: Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer. J Gastrointest Surg 2011, 15:551-557.

180.

Cho CS, Kooby DA, Schmidt CM, Nakeeb A, Bentrem DJ, Merchant NB, Parikh AA, Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins WG, and Weber SM: Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg 2011, 253:975-980

181.

Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown RE, St Hill CR, Hagendoorn L, Martin RC, Stromberg AJ, and Scoggins CR: Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 2011, 77:992997

182.

Farmer RW, , Kralj I, Valdata A, Urbano J, Enguix DP, Monaco RG, Scoggins CR, McMasters KM, Rustein L, and Martin RC: Hepatic arterial therapy as a bridge to ablation or transplant in the treatment of hepatocellular carcinoma. Am Surg 2011,

38

CURRICULUM VITAE

January 5th, 2014

77:868-873 183.

Li Y, Martin RC: Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med 2011:541209

184.

Li Y, Reuter N, Li XS, Martin RCG. Manganese superoxide dismutase chemoprevention in a murine hepatitis associated injury model. Journal of Cancer Therapy 2011;2:431-440.

185.

Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, McMasters KM, Cho CS, Winslow ER, Wood WC, and Staley CA, III: Importance of low preoperative platelet counts in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg 2011, 212:638-648

186.

Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, and McMasters KM: Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab. Ann Surg 2011, 254:591-597

187.

Martin RC, Rustein L, Perez ED, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj I, Bosnjakovic P, and Tatum C: Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry. J Am Coll Surg 2011, 213:493-500

188.

Martin RC, Kooby DA, Weber SM, Merchant NB, Parikh AA, Cho CS, Ahmad SA, Kim HJ, Hawkins W, and Scoggins CR: Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system. J Gastrointest Surg 2011, 15:175-183 2011 Best J of GI Surg Paper Award Winner

189.

Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M, Padr R, Rocek M, Scupchenko A, and Tatum C: Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol 2011, 18:192-198

190.

Picozzi VJ Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC, Wilfong LS, Rothenberg ML, Posner MC, and Pisters PW: Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol 2011, 22:348-354

191.

Ramsey AM and Martin RC: Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg 2011, 15:1633-1642 39

CURRICULUM VITAE

January 5th, 2014

192.

Schiffman SC, Li Y, Xiao D, Li X, Aiyer HS, and Martin RC: The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression. J Surg Res 2011, 171:623-630

193.

Schiffman SC, McMasters KM, Scoggins CR, Martin RC, and Chagpar AB: Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg 2011, 213:45-52

194.

Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR, McMasters KM, and Martin RC: Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg 2011, 201:519-524

195.

Schiffman SC, Metzger T, Dubel G, Andrasina T, Kralj I, Tatum C, McMasters KM, Scoggins CR, and Martin RC: Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol 2011, 18:431-438

196.

Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl M, and Martin RC: Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost. Oncologist 2011, 16:594-601

197.

Whitney R, , Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K, and Martin RC: Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res 2011, 166:236-240

198.

Cannon RM, , Legrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho CS, Brinkman A, Weber S, Winslow ER, Kooby DA, Chu CK, Staley CA, Glenn I, Hawkins WG, Parikh AA, Merchant NB, McMasters KM, Martin RC, Callender GG, Scoggins CR. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford). 2012 Apr;14(4):228-35.

199.

Callender GG, Gershenwald JE, Egger ME, Scoggins CR, Martin RC 2nd, Schacherer CW, Edwards MJ, Urist MM, Ross MI, Stromberg AJ, McMasters KM. A Novel and Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model. J Am Coll Surg. 2012 Feb 16. Vol 214(4):608-17

200.

Schiffman SC, Li Y, Martin RC. The Association of Manganese Superoxide Dismutase Expression in Barrett's Esophageal Progression with MnTBAP and Curcumin Oil

40

CURRICULUM VITAE

January 5th, 2014

Therapy. J Surg Res. 2011 Dec 13Vol 176(2): 535-541 201.

Mbah NA, Brown RE, Bower MR, Scoggins CR, McMasters KM, Martin RC. Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection. HPB (Oxford). 2012 Feb;14(2):126-31

202.

Martin RC, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R. Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin. Breast Cancer Res Treat. 2012 Apr;132(2):753-6363

203.

Dunki-Jacobs EM, Martin R. Endoscopic Therapy for Barrett's Esophagus: A Review of Its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Oncol. 2012 Vol 19(5): 1575-92

204.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM. Prognostic implications of anatomiclocation of primary cutaneous melanoma of 1 mm or thicker. Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5.

205.

Harper N, Li Y, Farmer R, Martin RC. Epidermal Growth Factor Expression in Esophageal Adenocarcinoma: A Clinically Relevant Target? J Gastrointest Surg. 2012 Vol 16:946-955

206.

Martin RCG, Geller DA, Espat JN, Kooby DA, Sellars M, Goldstein RG, Imagawa DK, Ulrich F, Scoggins CR. Safety and Efficacy of Trans Arterial ChemoEmbolization with Drug-Eluting Beads in Hepatocellular Cancer: An Optimal Therapy. Hepatogastroenterology 2012; Vol 59(113): 255-260.

207.

Li Y, Reuter NP, Liu Q, Li X, Martin RCG. Manganese Superoxide Dismutase Chemoprevention in a Murine Hepatitis Associated Injury Model. J of Cancer Therapy 2011; Vol 2(3): 431-440

208.

Joshi J, Robbins K, Valek V, Andrasina T, Boudny J, Padr R, O’Hara R, Tomalty D, Martin RCG. Hepatic Arterial Infusion – Doxorubicin Loaded Microsphere for the Treatment of Metastatic Breast Cancer to the Liver: Results from a Multi-Institutional Registry. Interven Oncology 2010.

209.

Brown RE, Abbas AE, Ellis SF, White S, Scoggins CR, McMasters KM, Martin RCG. A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety. J Am Col Surg 2011; Vol 212(4): 582-88. 41

CURRICULUM VITAE

January 5th, 2014

210.

Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl, M, Martin RCG. Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost. The Oncologist 2011; Vol 16(5): 594-601.

211.

Martin RCG, Irurzun I, Munchart J, Trofimov I, Scupchenko A, Tatum C, Narayanan G. Optimal Technique of Doxorubicin Beads in Hepatocellular Cancer: beads size, dose, and response. Korean J Hepatol 2011. Vol 17; 51-60.

212.

Farmer R, , Kralj I, Valdata A, Urbano J, Pérez Enguix D, Monaco R, Scoggins CR, McMaster KM, Rustein L, Martin RCG. Hepatic Arterial Therapy as a Bridge to Ablation or Transplant in the Treatment of Hepatocellular Carcinoma. Am Surg 2011; Vol 77(7): 868-873.

213.

Ramsey A, Martin RCG. Body Mass Index and Outcomes Following Pancreatectomy: A Meta Analysis. J or GI Surg 2011; Vol 15: 1633-1642.

214.

Aiyer HS, Li Y, Harper N, Myers SR, Martin RCG. Molecular changes in the esophageal epithelium after subchronic exposure to cigarette smoke in the presence of bile-acid reflux. Inhalational Toxicol 2011. Vol 23(5): 304-311.

215.

Schiffman S, Reuter NP, McMaster KM, Scoggins CR, Martin RCG. Overall Survival of Peri-Hilar Cholangiocarcinoma Compared to Primary Endoscopic Therapy. J Surg Onc 2010; Vol 105(1): 304-11.

216.

Martin RCG, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj I, Bosnjakovic P, Tatum C. Hepatic Arterial Infusion of Doxorubicin Loaded Microsphere for Treatment of Hepatocellular Cancer: a Multi-Institutional Registry. JACS 2011; Vol 213(4): 493-500.

217.

Martin RCG, Brown R, Puffer L, Block S, Scoggins CR, McMaster KM. Readmission Rates after Abdominal Surgery: The Role of Surgeon, Primary Caregiver, Home Health, and Sub-acute Rehab. Ann Surg 2011; Vol 254(4): 591-95.

218.

Martin RCG, Aiyer HS, Malik D, Li Y. Effect on Pro-inflammatory and Antioxidant Genes and Bioavailable Distribution of Whole Tumeric vs Curcumin: Similar Root but Different Effects. Food and Chemical Toxicology 2011; Vol 50(2); 227-31.

219.

Dunki-Jacobs E, Martin RCG. Endoscopic Therapy for Barrett’s Esophagus: A Review of its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Onc 2011; Vol 19(5): 1575-82.

42

CURRICULUM VITAE

January 5th, 2014

220.

Cannon RM, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj I, Bosnjakovic P, Tatum C, Martin RCG. Management of Diffuse Hepatocellular Cancer (≥ 10 Lesions) with Doxorubicin Loaded DC Bead is Safe and Effective Treatment Option. Onkologie 2012; Vol 35: 184-188.

221.

Mbah N, Brown RE, St Hill CR, Bower MR, Ellis SE, Scoggins CR, McMasters KM, Martin RCG. Impact of Post-Operative Complications on Quality of Life after Pancreaticoduodenectomy. J of Pancreas 2012: Vol 13(4): 387-393.

222.

Fox M, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Lymph Node Ratio is a Significant Predictor of Disease Specific Mortality in Patients Undergoing Esophagectomy for Cancer. Am Surg 2012; Vol 78(5): 528-34..

223.

Kotoyan R, Lindeman T, Tatum C, Robbins K, Martin RCG. Hepatic Arterial Therapy with Drug-eluting Beads in the management of Metastatic Pancreatic Carcinoma to the Liver: a Multi-Institutional Registry. J of Oncology 2012: Article ID 168303: 1-6.

224.

Lencioni R, Martin RCG, Geshwind J. Transcather treatment of HCC with DC Bead Doxorubicin (DEBDOX) Technical Recommendations. CVIR 2012 Vol 35: 980-985

225.

Schiffman SC, Li Y, Diao X, Li X, Aiyer HA, Martin RCG. The Association of Manganese Superoxide Dismutase Expression in Barrett’s Esophageal Progression with MnTBAP and Curcumin Oil Therapy. J Surg Res; Vol 176(2):535-41.

226.

Fouad H, Metzger T, Tatum C, Robbins K, Martin RCG. Hepatic arterial therapy with drug eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry. J of Oncology 2012; Article ID 292131: 1-6.

227.

Martin RCG, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R. Optimal Outcomes for Liver Dominant Metastatic Breast Cancer with Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin. Br C Res Tre 2012; Vol 132(2): 753-63.

228.

Martin RCG, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, Sharma V. Irinotecan Drug-eluting Bead in the Treatment of Chemo-Naïve Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial. J GI Surg 2012; Vol 16(8): 1531-38.

229.

Martin RCG, McFarlin K, Ellis S, Velanovich V. Irreversible Electroporation Therapy in the Management of Locally Advanced Pancreatic Adenocarcinoma. JACS 2012; Vol 215(3): 361-69. 43

CURRICULUM VITAE

January 5th, 2014

230.

O’Brien M, Pavlov V, Robbins K, Padr R, Martin RCG. Hepatic Arterial Therapy with Drug eluting Beads in the management of Metastatic Renal Cell Carcinoma to the Liver: a Multi-Institutional Registry. J Surg Rad 2012

231.

Lee T, Martin RCG. Readmission Rates After Abdominal Surgery: Can They Be Decreased to a Minimum? Advances in Surgery 2012. Vol 46:155-170

232.

Cannon B, Scoggins CR, Callender G, McMasters KM, Martin RCG. Laparoscopic Versus Open Resection of Hepatic Colorectal Metastases. Surgery 2012. Vol 152:567573

233.

Fox M, von Berkel V, Bousamra M, Sloan S, Martin RCG. Surgical Management of Pulmonary Carcinoid Tumors: Sub-lobar Resection versus Lobectomy. Am J Surg 2013.Vol 205(2):300-208

234.

Bower M, Scoggins CR, McMasters KM, Martin RCG. Body Mass Index and Liver Dysfunction Am J Surg 2013.

235.

Li Y, Brown R, Li X, Martin RCG. Incomplete Thermal Ablation of Hepatocellular Carcinoma Leads to Enhanced Cellular Viability and Resistance to Programmed Cell Death. J Surg Res. Vol. 181(2):250-255

236.

Rhodes Brown, Martin RCG. Management of Liver Dominant Metastatic Breast Cancer: Surgery, Chemotherapy, or Hepatic Arterial Therapy – Benefits and Limitations. Minerva Chirurgica 2012. Vol 67(4):297-308

237.

Cannon RM, Ellis S, Hayes D, Narayanan G, Martin RCG. Safety and Early Efficacy of Irreversible Electroporation for Hepatic Tumors in Proximity to Vital Structures. J Surg Onc 2012. Vol 107(5):544-549

238.

Martin RCG, R Salem, R Adam, E Dixon. Commentary Local regional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement. HPB 2013. Vol 15(2): 131-133.

239.

Martin RCG, McFarland K, Ellis S, Velanovich V: Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Potential Improvement in Overall Survival. Ann Surg Onc 2013. Vol 20 (S3):443-449.

240.

Egger, M, Martin RCG. The Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor. JACS 2012 Vol 216(4) :845-56

44

CURRICULUM VITAE

January 5th, 2014

241.

Edwards J, Scoggins CR, McMasters KM, Martin RCG. Combined Pancreas and Liver Therapies: Resection and Ablation In Hepato-Pancreatico-Biliary Malignancies. J Surg Onc 2012. Vol 107(7) 709-712

242.

Miller A, St Hill CR, Ellis SF, Martin RCG. Health-Related Quality of Life Changes Following Major and Minor Hepatic Resection: The Impact of Complications and Postoperative Anemia. Am J Surg 2013. Vol 206(4):443-450.

243.

Burnett NP, Dunki-Jacobs E, Callender GG, Anderson RJ, Scoggins CR, McMasters KM, Martin RCG. Evaluation of AFP Staging System for Hepatocellular Carcinoma in Non-cirrhotic Patients. Am Surgeon 2013. Vol 79 (7):716-22

244.

Martin RCG. Irreversible Electroporation: A Novel Option for Treatment of Hepatic Metastases. Current Colorectal Cancer Reports 2013 Vol 9(2):191-197.

245.

Cannon RM, Scoggins CR, Callender G, Quillo A, McMasters KM, Martin RCG. A Deviation Based Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection. Ann Surg Onc 2013. Vol 20(9): 2887-2892.

246.

Lee T, Martin RCG. Surgical Quality of Care in Esophageal Malignancies. Future Oncology 2012. Vol 9(4): 575-584.

247.

Anderson R, Dunki-Jacobs E, Callender G, Burnett N, Scoggins CR, McMasters KM, Martin RCG. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical Efficacy or Limited Benefit? Surgery 2014 154(4):755-760

248.

Li Y, Shi W, Zhang J, Zhang X, Martin RCG. Hepatic Protection and Anti-cancer Activity of Curcuma: A Potential Chemopreventive Strategy against Hepatocellular Carcinoma. Int J Oncol 44: 505-513, 2014

249.

Schiffman SC, Nowacki M, McMasters KM, Scoggins CR, Martin RC. Molecular factors Associated with recurrence and Survival Following Hepatectomy in Patients with Intrahepatic Cholangiocarcinoma: A Guide to Adjuvant Clinical Trials. J of Surg Onc 2014 Vol 109(2) Feb 2014:98-103

250. Mbah N, Scoggins CR, McMasters KM, Martin RCG. Impact of Hepatectomy Margin on Survival following Resection of Colorectal Metastasis: The Role of Adjuvant Therapy and Its Effects. Eur J Surg Onc Vol 39(12) Dec 2013:1394-1399. 251.

Dunki-Jacobs, E, Philips P, Martin RCG. Evaluation of Resistance as a Measure of Successful Tumor Ablation in Irreversible Electroporation of the Pancreas. JACS Feb 45

CURRICULUM VITAE

January 5th, 2014

2014 Vol 218(2):179-187 252.

Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Stroke Volume Variation in Hepatic Resection: A Replacement for Standard Central Venous Pressure Monitoring. Ann Surg Onc Feb 2014 Vol 21(2):473-78

253.

Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O’Grady E, Riling WS, Walker D, Martin RCG. Transcatheter Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded DC Bead (DEBIRI): Technical Recommendations. JVIR March 2014 Vol 25(3):365-369

254.

Martin RCG, Cannon RM, Brown RE, Ellis SF, Williams S, Scoggins CR, Abbas A. Evaluation of Quality of Life Following Placement of Self-Expanding Plastic Stents as a Bridge to Surgery in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer. The Oncologist 2014 Vol 19(3):259-65

255.

Anderson R, Dunki-Jacobs E, Burnett N, Scoggins CR, McMasters KM, Martin RCG. A Cost Analysis of Somatostatin use in the Prevention of Pancreatic Fistula After Pancreatectomy. W J Surg August 2014. Vol 38(8):2138-2144

256.

Martin RCG, Philips P, Hayes D, Bagla S,. Irreversible Electroporation of Unresectable Soft Tissue Tumors with Vascular Invasion: Effective Palliation. BMC Cancer. 2014, 14:540

257.

Martin RCG. Irreversible Electroporation for Locally Advanced Pancreatic Cancer. J GI Surg 2013. Vol 7(10):1850-1856

258.

Philips P, Hayes D, Martin RCG. Irreversible Electroporation Ablation (IRE) of Unresectable Soft Tissue Tumors: Learning Curve evaluation in the first 150 patients treated. PLOS One Medicine 2013. Vol 8(11).

259.

North AD, Schlegel M, Martin RCG. Gastroesophageal Reflux Disease-Related Symptom Assessment in Subjects with Malignant Dysphagia receiving Esophageal Stents. Am Surg December 2014. Vol 80(12):1260-1265

260.

Li X, Li Y, States VA, Li S, Zhang X, Martin RCG. The effect of black raspberry extracts on MnSOD activity in protection against concanavalin A induced liver injury. Nutrition and Cancer: International Journal 2014. Vol 66(6):930-937

261.

North AD, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Rilling WS, TC Gamblin, Martin RCG. Microwave Ablation for Hepatic Malignancies: A Call for Standard Reporting and Outcomes. Am J Surg 2014. Vol 208(2):284-294

46

CURRICULUM VITAE

January 5th, 2014

262.

Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Evaluation of Thermal Injury to Liver, Pancreas, and Kidney during Irreversible Electroporation in an In-vivo Porcine Model. Br J Surg 2014. Vol 101(9):1113-1121

263.

Philips P, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Caudate Lobe resections: A single center experience and evaluation of factors predictive of outcomes. W Journal Surg Onc 2013:11:220

264.

Agle S, Philips P, Martin RCG. Environmental Exposures, Tumor Heterogeneity, and Colorectal Cancer Outcomes. Curr Colorect Reports 2013 Vol 10(2): 189-194

265.

Bruenderman E, Martin RCG. High-Risk Population in Sporadic Pancreatic Adenocarcinoma: Guidelines for Screening. J Surg Res 2014 In Press

266.

Wehry J, Cannon B, Scoggins CR, Puffer L, McMasters KM, Martin RCG. Restrictive Blood Transfusion Protocol in Liver Resections Patients Reduces Blood Transfusions with No Increase in Patient Morbidity. Am J Surg 2014. In Press

267.

Philips P, Dunki-Jacobs E, Agle SC, Scoggins CR, McMasters KM, Martin RCG. The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery. HPB. 2014 Vol 16(12):1051-1055

268.

Doughtie CA, Priddy EE, Philips P, Martin RCG, McMasters KM, Scoggins CS. Preoperative dosing of low-molecular weight heparin in hepatopancreatobiliary surgery. The Am J of Surg. 2014 Vol 208(6):1009-1015

Accepted for Publication 1.

Martin RCG, Schwartz E, Adams J, Farah I, Derhake B. Intra-operative Anesthesia Management in Patients Undergoing Surgical Irreversible Electroporation of the Pancreas, Liver, Kidney, and Retroperitoneal Tumors. Anesthesia and Pain, 2014

2.

Akinwande OK, Martin RCG. Small (75-150 microns) versus medium sized drug eluting beads (DEBIRI) for the treatment of colorectal metastases – A Multi-institutional propensity score matching analysis. CVIR 2014

3.

Akinwande OK, Miller AR, Martin RCG. Concominant Capecitabine with Hepatic Arterial Infusion of Drug Eluting Beads in the management of metastatic colorectal cancer: A Multi-Institutional prospective study. – Anti Cancer Research 2014 47

CURRICULUM VITAE

January 5th, 2014

4.

Bruedermann E, Martin RCG. A Cost Analysis of a Pancreatic Cancer Screening Protocol in High-Risk Populations. Am J of Surg 2014

5.

Kwon D, McFarland K, Velanovic V, Martin RCG. Borderline and Locally Advanced Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin Accentuation. Surgery 2014. Vol 156(4):910-922

6.

Martin RCG Irreversible Electroporation in Locally Advanced Pancreatic Adenocarcinoma Body/Neck – Technique Paper. J of Gastrointestinal Oncology 2015

Submitted for Publication 1.

Lu Z, Li Y, Takwi A, Conklin D, Martin RCG, Li Y. A MicroRNA-Mediated NFkappaB Activation in Pancreatic Cancer Cells. J Nat Ca Institute 2008.

2.

St Hill CR, Brown R, Scoggins CR, McMasters KM, Martin RCG. Operative Duration and the Effects on Perioperative Outcomes after Pancreaticoduodenectomy. Hepatogastroenterology 2012.

3.

Farmer RW, Scoggins CR, McMasters KM, Martin RCG. Factors Predictive of Adverse Outcomes in Gallbladder Cancer. W J Surg 2012.

4.

St Hill CR, Mbah NA, Cannon R, Brown R, Kooby D, Staley C, Cho CS, Weber S, Winslow S, Scoggins CR, McMasters KM, Martin RCG. Laparoscopic versus Open Resection for Hepatocellular Carcinoma: Improvement in Outcomes and Similar Cost. Surgical Endoscopy 2013.

5.

Martin RCG. 2013 State of the Art Lecture: Evolving Management in Pancreatic Cancer: Use of Irreversible Electroporation in Unresectable Pancreatic Cancer. Hepatobiliary Surgery and Nutrition 2014.

6.

Akinwande OK, Ahmad SS, Van Meter T, Schultz B, Martin RCG. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: CT Findings in “Typical” Post-IRE Changes vs Local Recurrence”. Acta Radiologica

7.

Oliver A, Martin RCG. Evaluating the PK/PD and clinical efficacy of DC Bead - a doxorubicin- eluting polymer for treating liver cancer. Expert Opinion On Drug Metabolism and Toxicology 2014

8.

Martin RCG, Locatelli E, Li Y, Weizhong Z, Li S, Monaco I, Comes-Franchini M.

48

CURRICULUM VITAE

January 5th, 2014

Gold Nanorods and Curcumin-Loaded Nanomicelles for efficient in vivo Photothermal Therapy of Barrett’s Esophagus. ACS Nanomedicine 2014. 9.

Akinwande OK, Kim D, Edwards J, Brown R, Philips P, Scoggins CR, Martin RCG. Comparative analysis of transarterial therapy for unresectable hepatocellular carcinoma with portal vein thrombosis: Radioembolization (90Y) versus doxorubicin drug eluting beads (DEBDOX). Surgical Oncology

BOOK CHAPTERS 1.

Martin RCG, Karpeh M. An Internist’s Illustrated Guide to Gastrointestinal Surgery: Surgical Management of Gastric Tumors. The Humana Press, INC. Totowa, NJ. 2003.

2.

Martin RCG, McMasters KM. Surgical Complications, Risks and Consequences: Textbook Surgery: Complications, Risks and Consequences 7-Volume Series. Chapter Surgery: Complications, Risks and Consequences - Upper Abdominal Surgery (ISBN-13: 978-1447154358) - Springer

3.

Martin RCG, Kidd L, Hein DH. Colo-rectal Cancer Susceptibility: The Role of Polymorphic N-Acetyltransferase Genes (NAT1 and NAT2), Heterocyclic Aromatic Amines, and Gene-diet Interactions. CRC Press LLC 2005.

4.

Scoggins CR, Martin RCG, McMasters KM. Duodenal Cancer. In: Pollock RE, Curley SA, Ross MI, Perrier ND, editors. Advanced Therapy in Surgical Oncology, 1st Edition: Pp. 229-235.

5.

Yan Li, MD, PhD and Robert C.G. Martin, II, MD, PhD. Apoptosis in Carcinogenesis and Chemotherapy: Esophageal cancer. In: Apoptosis in Carcinogenesis and Chemotherapy, Editor George G Chen, MD, PhD, 1st Edition, Springer 2009.

6.

Schiffman S, Martin RCG. CT- and MR-guided Interventions in Radiology: Chapter 13 Technical basics of Microwave ablation. 2nd Edition, Springer 2011

7.

Robert C.G. Martin, II, MD, PhD, Hepatocellular Cancer, Springer 2009 Editors Kelly M. McMasters, MD, PhD and Jean-Nicholas Vauthey, MD, FACS Chapters: Chapter 8: Hepatocellular Carcinoma Arising in the Non-Viral, Non-Alcoholic Liver Chapter 18: Microwave Ablation Chapter 20: Chemoembolization with Drug-Eluting Beads

8.

St. Hill CR, Brown R, Martin RCG. Video Atlas of Advanced Minimally Invasive 49

CURRICULUM VITAE

January 5th, 2014

Surgery, Elsevier 2011, Editor: Mark Carlson Chapter 17: Laparoscopic Liver Resection 9.

Fouad H, Martin RCG. Regional Cancer Therapy for Advanced Tumors Jaypee Brothers Medical Publishing, 2011, Editor: Martin Goodman Chapter: Hepatic Arterial Therapies for Colorectal Metastases

10.

Suzanne C. Schiffman, MD and Robert C.G. Martin, II, MD, PhD. Arteriovenous Fistulae and Aneurysms of the Hepatic and Pancreatic Vasculature.In: LH Blumgart, editor. Surgery of the Liver, Biliary Tract and Pancreas. Fifth Edition. Elsevier Health Sciences.

11.

Woodall CE, Martin RC, McMasters KM, Scoggins CR. Hepatocellular carcinoma arising in the non-viral, non-alcoholic liver. In: McMasters KM, Vauthey JN, eds. Hepatocellular carcinoma: Targeted therapy and multidisciplinary care. New York: Springer, 2011:99-108.

12.

Schiffman S, Martin RCG. CT- and MR-guided interventions in radiology (Chapter 13) In: Technical Basics of Microwave Ablation; 2nd ed. New York: Springer, 2011.

13.

Philips, P, Martin RCG. Technical Considerations in Liver Surgery. Handbook of Pancreas and Hepatobiliary Surgery, 1st Edition. Lippincott 2013.

14.

Phillips P, Li Y, Martin RCG. Chapter 23: Low Energy DC currrent ablation in a mouse tumor model. 2nd Edition of Electroporation Protocols: Preclinical and Clinical Gene Medicine. Book: Electroporation Protocols: Preclinical and Clinical Gene Medicine. Springer Science Business Media, New York, NY, 2014

15.

Shumer E, Martin RCG. Chapter: Minimally Invasive Feeding Tube andEsophageal Stent Placement. Book: Minimally Invasive Foregut Surgery: Principles and Practices. 2014

16.

Spaulding T, Martin RCG. Chapter: Gastroienteropathic Neuroendocrine Tumors. Book: Current Controversies in Cancer Care for the Surgeon. Springer Science and Business Media, New York, NY 2014 OTHER PUBLICATIONS

1.

50

Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Martin RCG, Post-Graduate Course 16, American College of Surgeons, 88th clinical congress. Oct 6th10th, 2002 pg 26-28.

CURRICULUM VITAE 2.

January 5th, 2014

Martin,R.C.G., Hughes,K., Doll,M.A., Rothmann,N. and Hein,D.W. -102 polymorphism present at the -102 position from the transcription start site of the MnSOD gene. Genebank Bankit #574003, AY397775. Homo sapiens Manganese Superoxide Dismutase partial 5' UTR.

BOOK REVIEWS 1.

Atlas of General Surgery. Am J Surg 174:570, 1997.

SPEAKER PRESENTATIONS International: 1.

DC/LC Bead Open Surgical Registry in Primary and Metastatic Liver Tumors. European Conference of Interventional Oncology and Embolotherapy. Palazzo dei Congessi, Florence, Italy April 10th, 2008.

2.

DC/LC Bead Open Surgical Registry: The Power of A Registry. European Conference of Interventional Oncology and Embolotherapy. Hotel Brunelleschi Florence, Italy April 11th, 2008.

3.

DC/LC Bead Treatment for Neo-adjuvant for resectable and marginally resectable Hepatocellular. International Liver Cancer Association (ILCA), Chicago, IL, September 5th, 2008.

4.

DC/LC Bead Interim Analysis is Neoadjuvant Therapy for Metastatic Colorectal Cancer. 14th Congress of the European Society of Surgical Oncology, The Hague, The Netherlands, September 10-12th, 2008.

5.

LC/DC Bead Registry: Management in Metastatic and Primary Cancer of the Liver. 10th Congress of the Cardiovascular and Interventional Radiological Society of Europe, Copenhagen, Sweden, September 16th, 2008.

6.

Toxicity of irinotecan eluting beads in the treatment of hepatic malignancies: results of multi-institutional registry. 11th Congress of the Cardiovascular and Interventional Radiological Society of Europe, Lisbon, Portugal September 20th, 2009.

7.

Review of 350 Patient Drug Eluting Bead Registry: Breast, Melanoma, Cholangiocarcinoma and Esophageal. 11th Congress of the Cardiovascular and Interventional Radiological Society of Europe, Lisbon, Portugal September 20th, 2009. 51

CURRICULUM VITAE

January 5th, 2014

8.

Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic NonThermal Ablation using irreversible electroporation (IRE): initial USA Clinical Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

9.

Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic Thermal and Non-Thermal Ablation of the Pancrease – Past Clinical and Recent PreClinical Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

10.

Pre Congress Course – Multimodality Treatment of HPB Tumors: Topic Yttrium labled microsphers inneuroendocrine metastases. 9th World Congress of the Internation HepatoPancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

11.

Latest Clinical and Pathological result of Drug-Eluting Beads in the management of metastatic colorectal and hepatocellular carcinoma Symposium: Topic Drug Eluting Bead, Irinotecan (DEBIRI) Therapy of liver Metastasis from Colon Cancer with Concomitant FOLFOX-6 and anti-Angiogenic Therapy. 9th World Congress of the Internation Hepato-Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina

12.

Treatment of chemo naive colorectal liver metastasis by using irinotecan drug eluting bead with concomitant systemic fluorouracil and oxaliplatin. 12th World Congress on Gastrointestinal Cancer, June 30th – July 3rd, 2010, Barcelona, Spain

13.

Current Concepts in the Treatment of Colorectal Hepatic Metastasis – ECIO meets ESMO: Conventional Chemoembolization and Drug Eluting Beads. 2nd European Conference on Interventional Oncology. July 21-24th, 2010, Florence, Italy

14.

LC/DC Bead – How to Select Patients and Optimize Outcomes – Satellite Symposium: DC Bead in Metastatic Disease: DEBIRI in Combination with Systemic Chemotherapy: The optimal management of liver dominant disease. 2nd European Conference on Interventional Oncology. July 21-24th, 2010, Florence, Italy.

15.

Irreversible Electroporation: The next frontier for focal ablative therapy – Satellite Symposium: Non-Thermal Ablation using irreversible electroporation: The initial US Experience. 2nd European Conference on Interventional Oncology. July 21-24th, 2010, Florence, Italy.

16.

Moderator and Chairman at the Expert Meeting of Drug Eluting Bead Technology: Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads.

52

CURRICULUM VITAE

January 5th, 2014

Presentation – The Rationale for Irinotecan Drug Eluting Bead Therapy in Metastatic Colorectal Cancer, Empire Riverside Hotel, July 26th, Hamburg, Germany. 17.

Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads. Presentation the Multidisciplinary Management of Atypical Metastatic Disease to the Liver, Empire Riverside Hotel, July 26th, Hamburg, Germany.

18.

Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Mount Elizabeth Hospital, Singapore, September 29th, 2010.

19.

Optimal Hepatic Arterial Therapy for Primary and Metastatic Disease to the Liver. National University Hospital and Tan Tock Seng Hospital Multidisciplinary Conference, Singapore, September 29th, 2010.

20.

Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Annual Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota Bahru, Malaysia September 30th, 2010.

21.

Optimal Combination Systemic and Hepatic Arterial Therapy in Metastic Disease to the Liver. Annual Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota Bahru, Malaysia, September 30th, 2010.

22.

DC BeadM1 managing metastatic disease: Clinical rationale and pilot data. 12th Congress of the Cardiovascular and Interventional Radiological Society of Europe, Valencia, Spain October 2nd, 2010.

23.

Oncology Conference and Treatment planning Conference. Novel Treatments in the Management of Unresectable Metastatic Colorectal Cancer. Instituto Nacional de Câncer – INCA, Rio de Janerio, Brazil, June 28th, 2011.

24.

Oncology Grand Rounds The treatment of hepatic tumors, the chemoembolization, their indications, results and applications. Hospital Santa Rita - Sta. Casa de Porto Alegre, Brazil. June 29th, 2011

25.

Oncology Tumor Board – Grand Rounds. Multi-Disciplinary Management of Metastatic Colorectal Cancer. Hospital de Clinicas de Porto Alegre. Porto Alegre, Brazil. June 29th, 2011

26.

Oncology Multi-Disciplinary Treatment Conference. Update in treatment of metastatic tumors to the liver: Chemoembolization - indications and results. Hospital Mae de Deus, Instituto do Cancer, HCPA, Hospital Conceicao, PUCRS. Porto Alegre, Brazil. June 29th, 2011. 53

CURRICULUM VITAE

January 5th, 2014

27.

Chiliean – Americas Hepato-Pancreatico-Biliary Post Graduate Course. New Technologies for Liver-Directed Therapy: Microwave Ablation, Radioembolization and Drug-Eluting Beads. Clinical Alemana, Santiago, Chile, July 1st, 2011.

28.

Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal Cancer. Hospital AC Carmago, Sao Paulo, Brazil, August 9th, 2011.

29.

Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal Cancer. Hospital Albert Enstein, Sao Paulo, Brazil, August 10th, 2011.

30.

Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE). Drug Eluting Beads and Transarterial Chemoembolization in HCC prior to resection and transplant. Buzios, Brazil August 11, 2011.

31.

Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE). Decision making strategies for resection and the role of loco regional therapies in metastatic colorectal cancer. .Buzios, Brazil August 11, 2011.

32.

Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE). Ablative Therapies for Metastatic Colorectal Cancer. Buzios, Brazil August 11, 2011.

33.

Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE). Drug Eluting beads in the management of Metastatic Colorectal Cancer. Buzios, Brazil August 11, 2011.

34.

Asian Pacific HPBA Congress. The use of Irinotecan Drug Eluting Beads: A Surgeons Perspective. Melbourne, Australia, September 29th, 2011.

35.

The Interdisciplinary Treatment of Liver Tumors (ITLT) – Chairman of Session: Liver Metastasis of Colorectal Cancer. The Atlantic Conference Center, Essen Germany, October 29th, 2011.

36.

The Interdisciplinary Treatment of Liver Tumors (ITLT) – Speaker at Session: Liver Metastasis of Colorectal Cancer: Chemoembolization of colorectal liver metastasis: conventional or drug eluting beads. The Atlantic Conference Center, Essen Germany, October 29th, 2011.

37.

Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011 – Munich, Germany September 18th, 2011 – Updates in Irreversible Electroporation of the Liver and Pancreas – Results Multi-institutional Registry.

54

CURRICULUM VITAE

January 5th, 2014

38.

The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012 in Florence, Italy. Is there a place for local chemotherapy to the liver?

39.

The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012 in Florence, Italy. Irreversible Electroporation in Locally Advanced Pancreatic Cancer.

40.

Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012 – Lisbon, Portugal September 18th, 2012 – Interim results of a first-line evaluating DEBIRI in combination with FOLFOX and Avastin in Colorectal Liver Metastasis.

41.

The European Society of Surgical Oncology 32nd Congress, Valencia, Spain September 19th, 2012 – Embolic Drug Eluting Beads in the Management of Colorectal Liver Metastasis.

42.

SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario Canada, February 1st, 2013 - Ablation Nation: Do we need new ablation technologies? What do they add?

43.

SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario Canada, February 2nd, 2013 - How much liver can you take out?: Preop optimization techniques: downstaging and PVE.

44.

SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario Canada, February 1st, 2013 – Sequencing of Locoregional Therapy and Chemo for HCC.

45.

Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013, Budapest, Hungary – Drug Eluting Beads in Metastatic Colorectal Cancer.

46.

Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013, Budapest, Hungary – Optimal Management in Metastatic Colorectal Cancer- Tumor Board Discussion.

47.

Chariperson – Moderator for IHPBA 11th World Congress 2014, Seoul, Korea, March 24th, 2014 – Various Issues in Colorectal Liver Metastasis

48.

Invited Speaker to the IHPBA 11th World Congress 2014, Seoul Korea, March 23rd, 2014 – Session: Updates in Image-Guided and Computer-Assisted Liver Surgery – Optimal Intra-operative navigation for Irreversible Electroporation of Locally Advanced Pancreatic Cancer.

49.

International Academic Conference on Irreversible Electroporation in Tumor Ablation. May 10th 2014, 301 Military Hospital Beijing China. Optimal Patient Selction and 55

CURRICULUM VITAE

January 5th, 2014

Outcomes for IRE in Liver and Pancreatic Tumors. 50.

International Academic Conference on Irreversible Electroporation in Tumor Ablation. May 11th 2014, Prince of Wales Hospital, Chinese Medical University, Hong Kong China. Optimal Patient Selction and Outcomes for IRE in Liver and Pancreatic Tumors.

51.

CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Pancreatic Tumors Irreversible Electroporation.

52.

CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Chair, moderator of session - MRI Gated Focuses Ultrasound and IRE.

53.

The 10th Chinese Conference of Minimally Invasive Therapy in Oncology / The 1st Scientific Meeting of Asia Pacific Association of Imaging Guided Therapy in Oncology – Shanghai, China, Nov 7th 2014 – IOUS-Guided Tumor Ablation – History, Current Situation, and Future

54.

2014 Capital Ultrasound Forum / The 2nd Ultrasonic Medical Academic Conference – Beijing, China Nov 8th 2014. – 3D Ultrasound Enhanced Imaging in Advanced Liver and Pancreatic Ablations

55.

Workshop of Intraoperative Ultrasonography in Hepatobiliary Surgery – Beijing China, Nov 8th 2014 – Novel Intra-operative Ultrasound Techniques for Liver Ablation

National: 56.

Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Post-Graduate Course 16, 88th Congress, American College of Surgeons, San Francisco Oct 6th-10th, 2002.

57.

Blood Utilization in Surgical Oncology. Ortho Biotech Surgery – Johnson and Johnson 2006 Summit, Phoenix AZ, April 2006.

58.

Ablative Approaches to Pulmonary, Renal, and Bone Tumors. The Society of Surgical Oncology Annual Meeting, San Diego, CA, March 2006.

59.

Optimal Multimodality Care of Esophageal Cancer. Boston Scientific National Sales Meeting. Orlando, FL, January 31st, 2007.

60.

New Uses in Esophageal Stenting for the treatment of Esophageal Diseases: Benign and Malignant. Boston Scientific National Marketing Meeting. Sanibel Island, FL, March 8th, 2007.

56

CURRICULUM VITAE

January 5th, 2014

61.

Moderator, Optimizing the Management of Anemia in Cancer Surgery. Society of Surgical Oncology, 60th Annual Cancer Symposium, Washington, D.C., March 15th18th, 2007.

62.

The Use of Intra-operative Auto-transfusion in Surgical Oncology: A True Contraindication? Society of Surgical Oncology, 60th Annual Cancer Symposium, Washington, D.C., March 15th-18th, 2007. Invited speaker: Interventional Radiology Symposium, Little Rock, Arkansas, May 15th, 2007: New Modalities in the Treatment of Primary and Secondary Liver Cancer.

63.

Invited speaker to the SAGES and AHPBA 2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: SAGES/ AHPBA Panel: Contemporary Issues and Outcomes: Hepatic Tumor Ablation: The Physics of Ablation.

64.

Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: remote ischemia preconditioning modulates hepatic microcirculation through the hemeoxygenases pathway in a rat model of warm ischemia reperfusion injury of the liver.

65.

Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: Guidelines for power and time variables for Microwave Ablation in a porcine liver

66.

Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: Factors influencing Perioperative Blood Transfusion in Patients undergoing Major Hepato-Pancreatico-Biliary procedures.

67.

Moderator of World Congress Interventional Oncology, Washington DC in May 14-17th, 2007. RFA and Embolization for the Management of soft Tissue Malignancies: liver and breast.

68.

Invited Speaker to World Congress Interventional Oncology, Washington DC in May 1417th, 2007. Laparoscopic Hepatic Resections with a Novel Surgical Device: the Habib 4X

69.

Invited Speaker to Huntsville Alabama, Clinical Research Meeting, July 26th, 2007. New Hepatic Arterial Modalities in the Treatment of Primary/ Secondary Liver Cancer.

70.

Invited Speaker to University of Florida, Shands, Jacksonville, Division of Surgical Oncology Grand Rounds August 22, 2007. Novel Treatments in Esophageal Adenocarcinoma. 57

CURRICULUM VITAE

January 5th, 2014

71.

Invited Speaker to University of Florida Interventional Radiology Oncology Seminar, Gainesville, FL, September 6th, 2007. Novel Treatments in the Hepatic Intra-arterial Therapy of the Liver.

72.

Guest Faculty to Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency Ablation, Charlotte, NC September 16-17th.

73.

Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency Ablation, Charlotte, NC September 16th. Radiofrequency Ablation for Colorectal Hepatic Metastasis.

74.

Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency Ablation, Charlotte, NC September 17th. Microwave Ablation for Primary and Secondary Hepatic Tumors.

75.

University of North Carolina Gastroenterology Grand Rounds, September 18th, 2007. Invited Speaker: Novel Endoscopic Therapies in Esophageal Adenocarcinoma.

76.

Hulston Cancer Center Symposium, Springfield, MO, September 21st, 2007. Invited Speaker: Advances in the Multi-Disciplinary Care of Hepatic and Pancreatic Cancers.

77.

Duke University Multi-disciplinary Gastrointestinal Grand Rounds, Raleigh, NC, October 11th, 2007. Invited Speaker: Novel Endoscopic Therapy in Esophageal Adenocarcinoma.

78.

93rd Annual Clinical Congress of the American College of Surgeons, Current Management of Hepatoma Session, October 10th, 2007 New Orleans, LA. Invited Speaker: Non-operative, non-ablative therapies for hepatoma: Embolization, chemoembolization, and radioactive microsphere treatment, systemic therapy, and more.

79.

Kansas University Interventional Hepatic Therapy Grand Rounds, October 31st, 2007 Kansas City, Kansas. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and Secondary Liver Tumors.

80.

Medical College of Georgia Department of Surgery, Upper Gastrointestinal Multidisciplinary Grand Rounds, November 2, 2007, Augusta, GA. Invited Speaker: Novel Endoscopic Therapies in Esophageal Adenocarcinoma.

81.

St. Clare Regional Hospital/ Thompson Cancer Center Grand Rounds, November 12th, 2007, Knoxville, TN. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and Secondary Liver Tumors.

58

CURRICULUM VITAE

January 5th, 2014

82.

Tampa General Hospital Interventional Radiology Department, Cancer Conference, November 15th, 2007, Tampa, FL. Invited Speaker: Recent Advances in TransArterial Embolization for Primary and Metastatic Liver Cancer.

83.

Piedmont Hospital System Tumor Board, Cancer Conference, November 28th, 2007, Atlanta, GA. Invited Speaker: Recent Advances in TransArterial Embolization for Primary and Metastatic Liver Cancer.

84.

Trinity Hospitals Tumor Board, Cancer Conference, December 13th, 2007, Minot, ND. Invited Speaker: Advances in the Surgical Quality of Colon Cancer.

85.

The Society of Surgical Oncology 61st Annual Cancer Symposium, March 13th Sheraton Chicago Hotel, Chicago, IL. Microwave Ablation of Liver Tumors: Results of Clinical Trials.

86.

Louisiana State University, Cancer Conference, May 14th, 2008, Shreveport, LA. Invited Speaker: Advances in Hepatic Arterial Therapy for Primary and Metastatic Liver Cancer.

87.

Distinguished Speaker: Contrast Enhanced Hepatic Ultrasound, B-K Medical Systems Colon Rectal Focus Group, Kennebunkport, ME, August 9-10th, 2008.

88.

Mount Sinai Medical Center / Miami Heart Institute, October 3rd, 2008, Miami, FL., Invited Speaker, Tumor Board: Interim Analysis of International LC/DC Bead Registry for Primary and Metastatic Lesions to the Liver.

89.

Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA, Clinical Dilemmas in Cancer Surgery: Vascular Resections in Pancreatic Cancer

90.

Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA, Clinical Dilemmas in Cancer Surgery: Laparoscopic Resection of Liver Tumors

91.

Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA, Clinical Dilemmas in Cancer Surgery: Treatment of Unresectable Liver Tumors: Radiofrequency and Microwave Ablation, Intra-arterial Radiotherapy and Chemotherapy

92.

The Association for Academic Surgery – Fall Leadership Course, October 10th, 2009, Chicago, IL - Choosing the Right Job and Negotiating for Academic Success

93.

The Academic Surgical Congress: Hot Topic Symposium: Liver Tumors: Expert Update: Treating Primary and Secondary Hepatic Malignanices with Radiofrequency or 59

CURRICULUM VITAE

January 5th, 2014

Microwave Ablation: Patient Selection and Outcomes. February 5th, 2010, San Antonio, TX. 94.

The Academic Surgical Congress: Instructor: Animate Hands-on Session: Beginner and Advanced Liver Ultrasound Modules. February 5th, 2010, San Antonio, TX.

95.

The Society of Surgical Oncology: Symposium Speaker: Optimizing Outcomes in Metastatic Gastrointestinal Neuroendocrine Tumors. March 7th, 2010, St. Louis, Mo

96.

The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Electroporation: Which Patients and Why? Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24, 2011

97.

The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. All These Interventional Options: Where Does the Surgeon Fit In? – Philosophical Concepts? Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24, 2011

98.

The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Cancer Therapies: A Multidisciplinary Approach. Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24, 2011.

99.

The 97th American College of Surgeons Annual Meeting – Moderator - Management of Complex Cancers: Upper GI Tumors. Moscone Center, San Francisco, CA October 25th, 2011.

100.

The 97th American College of Surgeons Annual Meeting – Speaker- Management of Complex Cancers: Upper GI Tumors. Topic Surgical Management of GI Neurendocrine Tumors. Moscone Center, San Francisco, CA, October 25th, 2011.

101.

Updates in Ablation Therapy – Thermal to Non-Thermal Modalities. Dekalb Angio Club, Atlanta, GA, November 8th, 2011.

102.

Irreversible Electroporation – Initial Results in the treatment of locally advanced pancreatic cancer – planned Phase II Trial. AHPBA National Meeting, Eden Roc, Miami FL., March 7th, 2012.

103.

Optimal management of metastatic neuroendocrine tumors with oral-targeted agents and long-acting injection. 65th Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando, FL, March 22nd 2012.

104.

Surgery for Non-Invasive Disease: Does it Save Lives? Barrett’s Esophagus. 65th Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando, FL, March 22nd 2012.

60

CURRICULUM VITAE

January 5th, 2014

105.

Interactive Tumor Board – Colorectal Cancer – with and without Liver metastasis. 65th Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando, FL, March 24nd 2012.

106.

Analogic Investor Education Day – NASDAQ – “Ultrasound Guidance – Essential Tool in the Operating Room”. October 4, 2012, New York, NY.

107.

Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local Control and Quality of Life: Department of Surgery Grand Rounds – Wake Forest University – Bowman Grey Hospital, Winston Salem NC, October 31st 2012.

108.

Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local Control and Quality of Life: Department of Surgery Carolinas Medical Center, Charlotte, NC, October 31st 2012.

109.

Current Trial in DEBIRI. SYNERGY 2012: A Multidisciplinary Approach to Interventional Oncology, Miami, FL. November 10th, 2012.

110.

Surgical Ablation of Pancreatic Cancer. SYNERGY 2012: A Multidisciplinary Approach to Interventional Oncology, Miami, FL. November 11th, 2012.

111.

Ultrasound Methods of Tumor Ablation in HPB Surgery. AHPBA National Meeting, Eden Roc, Miami FL., February 20th, 2013.

112.

What Are The Most Important Clinical Questions? How to Access What is Most Relevant to our Members. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.

113.

Predictors of Readmission and Quality Parameters in Liver Surgery. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.

114.

Safety of Hepatectomy after Yttrium-90 Therapy. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.

115.

Electroporation of Liver and Pancreas: Still Experimental or Accepted Practice? A Opinion. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.

116.

Advanced energy/laparoscopy in Pancreatic – Esophagogastric Surgery. 66th Annual Society of Surgical Oncology Caner Symposium. New Harbor MD, March 7th, 2013

117.

STATE OF THE ART CONFERENCE: Pancreas – 54th Annual Meeting – The Society 61

CURRICULUM VITAE

January 5th, 2014

for Surgery of the Alimentary Tract, May 19th, 2013, Orlando Fl. The Use of Irreversible Electroporation in Unresectable Pancreatic Cancer. 118.

Hepatic Tumor Ablation Technologies – 2nd Annual AHPBA Fellows Minimally Invasive Surgery Course – August 19th, 2013

119.

Laparoscopic Pancreatic Resection - 2nd Annual AHPBA Fellows Minimally Invasive Surgery Course – August 19th, 2013

120.

DEBIRI – Update on Clinical Trials and Results, 3rd Annual SYNERGY Meeting, Eden Roc, FL – October 19th 2013

121.

Margin Accentuation in Pancreatic Cancer – Results and Outcomes, 3rd Annual SYNERGY meeting, Eden Roc Fl, October 19, 2013

122.

Surgical Management of Metastatic Colorectal Trials and Metastatic Neuroendocrine Tumors. Symposium on the Management of Liver Metastasis, Methodist Dallas Medical Center / Methodist Health System Clinical Research Institute, October 26th, 2013

123.

Ultrasound Methods in Tumor Ablation – 2014 Annual Meeting Americas HepatoPancreatico-Biliary Association, Eden Roc, Miami FL.

124.

US Coding and Billing for the Surgeon - – 2014 Annual Meeting Americas HepatoPancreatico-Biliary Association, Eden Roc, Miami FL.

125.

Surgical Management of GI Neurendocrine Tumors – 2014 Annual Scientific Meeting, February 22nd 2014 – Southeastern Surgical Congress.

126.

Invited Moderator – Pancreas and GI Session -Society of Surgical Oncology 67th Annual Cancer Symposium – Phoenix, Az – March 15th 2014

127.

Invited Speaker – Session Surgeon Directed Tumor Ablation - Society of Surgical Oncology 67th Annual Cancer Symposium – Phoenix, Az – March 12th 2014 – Advances of IRE in Pancreas.

128.

Invited Speaker – Session Metastatic Colorectal Cancer – Synergy 2014 – A Multidisciplinary Effect to Interventional Oncology November 15th 2014 – Irinotecan Loaded Beads for the Treatment of Unresectable Colorectal Liver Metastasis

129.

Invited Speaker – Session Pancreas – Synergy 2014 - A Multidisciplinary Effect to Interventional Oncology November 16th 2014 – Resistance as a Measure of Successful Tumor Electroporation during IRE of the Pancreas

62

CURRICULUM VITAE 130.

January 5th, 2014

Invited Disccussant – Western Surgical Association 2014 Annual Meeting, Indian Wells CA, Nov 11th - Is Liver Transplantation Appropriate for Patients with Potentially Resectable de novo Hilar Cholangiocarcinoma?

Regional: 131.

Neoadjuvant Therapies in Esophageal Cancer. Central Baptist Hospital Oncology Research Symposium, Lexington, KY. July 27th, 2006.

132.

Surgical Management of Gastric and Distal Esophageal Lesions. Kentucky Medical Association Annual Meeting, Kentucky Chapter, American College of Surgeons, September 10th, 2003.

133.

Advances in Hepatic Tumor Ablations. Central Surgical Association Louisville, KY. March 2006.

134.

Moderator, American Hepato-Pancreatico-Biliary Association Meeting, Hepatic and Pancreatic Free Paper Session, Eden Roc Hotel, Miami, Florida, March 11th, 2006

135.

Surgical Treatment of Malignant Liver Tumors: Resection and Ablative Options. Southern Society of Clinical Surgeons, Louisville, KY, April 10th, 2006.

136.

Optimal Management for Colorectal Cancer: Multi-disciplinary Care. Grand Rounds Seymour, Indiana Cancer Center, October 5th, 2006.

137.

Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced Staged Colon Cancer. Hurley Medical Center Tumor Board, Flint MI, Jan 17th, 2007

138.

Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced Staged Colon Cancer. Saginaw Medical Specialist Multidisciplinary Meeting, Saginaw, MI Jan 17th, 2007.

139.

Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced Staged Colon Cancer. Utley Medical Center, Lafayette, IN, Jan 25th, 2007

140.

Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced Staged Colon Cancer. Fort Wayne Medical Oncology Meeting, Fort Wayne, IN, Jan 25th 2007.

63

CURRICULUM VITAE

January 5th, 2014

141.

Optimal Surgical Management of Stage III and Stage IV colorectal cancer. Parkview Hospital Tumor Board, Ft Wayne, IN May 2007.

142.

Options for Localized Hepatocellular Cancer: Irreversible Electroporation. 2014 Hepatocellular Carcinoma: Advances and Challenges for Rapidly Increasing Malignancy. University of Cincinnati, Cincinnati OH, Sept 27th, 2014.

Local: 143.

Synchronous Colorectal Metastasis: Staged vs Simultaneous Resection? Surgical Grand Rounds Memorial Sloan-Kettering Cancer Center, March 11th, 2002.

144.

Surgical Management of Primary Liver Tumors. University of Louisville Department of Surgery Grand Rounds, November 15th, 2002.

145.

Cancer of the Pancreas. University of Louisville Department of Surgery Grand Rounds, August 15th, 2003.

146.

IntraOperative MRI Guided Liver Tumor Ablation. Second Annual IntraOperative MRI Symposium. Norton Hospital Cancer Center, November 8th, 2003.

147.

Surgical Therapy in Barrett’s Esophagus. Barrett’s Esophagus Symposium, Louisville, KY. November 13th, 2004.

148.

Tumors of the Pancreas: Diagnosis and Management. University of Louisville Surgical Grand Rounds. Louisville, KY, February 21st, 2006.

149.

Advances in the Surgical Treatment of Cancer. Second Annual Louisville Update in Oncology, ASCO Review, Louisville, KY, July 15th, 2006.

150.

Update on the Treatment of Liver Tumors. Kentucky Chapter American College of Surgeons, Fall Meeting Sept 15th-16th, 2006.

151.

Advances in Liver and Pancreatic Tumor Treatments. Norton Healthcare Perioperative Symposium Sept 9th, 2006.

152.

Management of Pancreatic Cancer. 6th Annual CEU Roundtable Conference for Healthcare Professionals, October 12th, 2006.

153.

University of Louisville Grand Rounds. Benign Liver Tumors and their Management. October 20, 2006.

64

CURRICULUM VITAE

January 5th, 2014

154.

Gastroenterology/ Hepatology Teaching Conference. Advances in Barrett’s Esophagus Basic Science Research. November 9th, 2006.

155.

Pikeville Osteopathic School. Clinical Continutiy Lecture for 1st and 2nd year osteopathic students. What is Cancer? How do you prevent it? November 17th, 2006.

156.

Multimodality Gastrointestinal Cancers University of Louisville, James Graham Brown Cancer Center. Surgical Managagement of Metastatic Gastrointestinal Cancers: Can it be Curative? November 18th, 2006.

157.

University of Louisville Department of Surgery Grand Rounds. Barrett’s Esophagus August 24th, 2007.

158.

University of Louisville, James Graham Brown Cancer Center, ASCO Review – Update in Oncology, September 8, 2007. Advances in Upper Gastrointestinal and HepatoPancreatico-Biliary Malignancies.

159.

University of Louisville, Jewish Hospital, Advances in Laparoscopic Hepato Pancreatico Biliary Surgery, September 14th, 2007. Outcomes in Laparoscopic Hepato Pancreatico Biliary Surgery.

160.

University of Louisville, James Graham Brown Cancer Center, 2nd Annual Gastrointestinal and Hepato-Pancreatico-Biliary Multidisciplinary Conference, October 27th, 2007. Invited Speaker: Surgical Treatment in Pancreatic Cancer: Current State of the Art.

161.

Kentucky Chapter of the American College of Surgeons Meeting, November 3rd, 2007, Louisville, Ky. Invited Speaker, Advances in Minimally Invasive Treatment of Liver Tumors.

162.

Norton Healthcare Endoscopy Symposium, November 15th, 2008, Louisville, Ky. Invited Speaker, Advances in Esophageal Stenting for Esophageal Strictures: Benign and Malignant.

163.

First and Second Year Surgical Club University of Louisville, Olmstead, Louisville Ky, October 14th 2013. Invited Speaker – Perspectives on a Career in Surgical Oncology.

164.

Radiation Oncology Grand Rounds - Advances in locally advanced pancreatic cancer: Optimal Palliation and Improved Quality of Life Time. Sept 26th, 2014.

Abstract Presentations: 65

CURRICULUM VITAE

January 5th, 2014

1.

Microbial Expression of the Human Estrogen Receptor Gene: Comparison of the Receptor Protein with that of Human Breast Cancer. Poster Presentation, University of Louisville Research Day, Louisville, KY, May 1992.

2.

Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical Patients. Oral Presentation, Louisville Surgical Society, Louisville, KY, February 1997.

3.

Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical Patients. Oral Presentation, Kentucky Chapter of the American College of Surgeons, Lexington, KY, April 1997. Winner Resident Paper Competition.

4.

Initial Neck Exploration in Untreated Hyperparathyroidism. Poster presentation, Southeastern Surgical Congress, Tampa, FL, February 1999.

5.

The Use of Intraoperative Methylene Blue in Parathyroid Resection. Poster Presentation, Southeastern Surgical Congress, Tampa, FL, February 1999.

6.

Initial Neck Explorations in Untreated Hyperparathyroidism. Oral Presentation, Louisville Surgical Society, Louisville, KY, March 1999.

7.

Special Problems in the Surgical Care of the Melanoma Patient. Oral Presentation, Kentucky Chapter of the American College of Surgeons, Louisville, KY, May 1999.

8.

Cost Comparison of Endoscopic Stenting versus Surgical Treatment for Unresectable Cholangiocarcinoma. Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ, McMasters KM. Poster presentation, Society of American Gastrointestinal Endoscopic Surgeons, Atlanta, GA, March 29-April 1, 2000.

9.

Optimal Gamma Probe Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Nationwide Multi-Institutional Study. Martin RCG, McMasters KM, Wong SL, Tuttle TM, Edwards MJ. Oral Presentation, Kentucky Chapter of the American College of Surgeons, Lexington, KY, March 2000. Louisville Surgical Society, Louisville, KY, April 2000. Winner of the Resident Paper Competition.

10.

A Microsatellite Marker for Colorectal Cancer Associated with the Human MSH2 Gene. Martin RCG, Hunt LE, Eichenberger MR, Galandiuk S. Kentucky Chapter of the American College of Surgeons, Lexington, KY, March 2000.

11.

Do Facial Fractures Protect the Brain or Are They a Marker for Severe Head Injury? Martin RCG, Cerrito P, Spain DA, Richardson JD. Oral Presentation, 108th Annual Scientific Session of the Western Surgical Association, Dana Point, CA, November 12-15,

66

CURRICULUM VITAE

January 5th, 2014

2000. 12.

The Quality of Complication Reporting in the Surgical Literature. Martin RCG, Brennan MF, Jaques DJ. Oral presentation, Southern Surgical Association, Hot Springs, VA, December 2001.

13.

Randomized Control Trials: Does Additional Training Increase Participation? Martin RCG, Brennan MF, Polk HC Jr, Jaques DJ. Oral presentation, The American College of Surgeons Clinical Congress, New Orleans, LA. October 2001.

14.

Highest Isotope Count Does Not Predict Sentinel Node Positivity in all Breast Cancer Patients. Martin RCG, Fey J, Borgen PI, Cody HS. Oral Presentation, Society of Surgical Oncology, Washington, DC, March 15-18, 2001.

15.

Solid-Pseudo Papillary Tumors of the Pancreas: A Surgical Enigma. Martin RCG, Klimstra D, Brennan MF, Conlon KC. Poster presentation, Society of Surgical Oncology, Washington, DC, March 15-18, 2001.

16.

Extended Local Resection for Advanced Gastric Cancer: Increased Survival vs Increased Morbidity? Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Oral Presentation, International Congress of Gastric Cancer, New York, N.Y., April 30-May 2, 2001.

17.

Achieving R0 Resection for Locally Advanced Gastric Cancer: Is it Worth the Risk for Multi-Organ Resection? Martin RCG, Brennan MF, Leung D, Karpeh, M. Poster Presentation, Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.

18.

Peritoneal Washings are not Predictive of Advanced Stage in Hilar Cholangiocarcinoma. Martin RCG, Fong Y, Dermatteo RP, Blumgart LH, Jarnagin WR. Poster Presentation, Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.

19.

Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? Martin RCG, Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart LH. Oral Presentation, Paper Session I, 88th congress, American College of Surgeons, San Francisco Oct 6th-10th, 2002.

20.

Management of Colorectal Metastasis. Martin RCG, Brown Cancer Center Tumor Conference, November 6th, 2002.

21.

Surgical Exposure For Partial Hepatectomy: Is There a Difference in Complications From Chevron versus Hockey Stisk Incision? Martin RCG, Cohen MS, Ben-Porat L, Goen M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR . Poster Presentation, SSAT 2003 67

CURRICULUM VITAE

January 5th, 2014

22.

Martin RCG, Fong Y, Dematteo RP, Jarnagin WR, Blumgart LH. Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. Oral Presentation, American Hepato-Pancreato-Biliary Congress, Feb 27-March2, 2003, Miami, FL.

23.

Martin RCG, McMasters KM. The Use of Intra-Operative MRI with Ablation of Hepatic Malignancies. Video Session, 56th Annual Cancer Symposium, March5-9, 2003, Los Angeles CA.

24.

Casos S, Martin RCG, McMasters KM. Advances in Hepatic Imaging. Video Session, 56th Annual Cancer Symposium, March 5-9, 2003, Los Angeles CA.

25.

Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation, SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology, American Association of Cancer Research, September 13-17, 2003, Key Biscayne, FL

26.

Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation, James Graham Brown Cancer Center Retreat, September 17th, The Olmstead, Louisville, KY.

27.

Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N Rothman and DW Hein. Association between the Manganese Superoxide Dismutase Gene (-9 T>C) polymorphism and gastric cancer. Poster Presentation, James Graham Brown Cancer Center Retreat, September 17th, The Olmstead, Louisville, KY.

28.

Martin RCG, Hughes K, Doll MA, Lang Q, Chow W, Lissowska J, Zatonski W, Rothman N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102) Genotypes and Risk of Gastric Cancer. American Association for Cancer Research, 95th Annual Meeting, March 27-31, 2004, Orlando, Florida.

29.

Li Y, Martin RC, Ellis SE, Ray M, Wo JM. A Novel External Esophageal Perfusion Rat Model for Reflux Esophagitis. AGA Poster Session, Digestive Disease Week, New Orleans, Louisiana, May 15-20, 2004 .

30.

Martin RC, Edwards MJ, McMasters KM. Initial Experience with Hepatic Arterial Infusion Pump Chemotherapy to the Liver. Oral Presentation. The Southwestern Surgical Congress, Monterray, CA, April 18th-21st, 2004.

31.

Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of

68

CURRICULUM VITAE

January 5th, 2014

Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Oral Presentation. 6th World Congress of the International Hepato-Pancreato-Biliary Association, Washington, DC, June 2-6, 2004. 32.

Martin RC, Casos S, Chao C, Wong SL, McMasters KM. Prolonged Survival after Radiofrequency Ablation of Synchronous Colorectal Liver Metastases. Published ASCO Proceedings. 2004 Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004.

33.

Martin RCG, Li Y, Hein D. Expression of NAT1 and NAT2 in Human Normal Lung and Bronchial Carcinoma. Third International Workshop on Arylamine N-Acetyltransferases, Vancouver Canada, August 27-28th, 2004.

34.

Martin RCG. The Big C: Cancer Prevention and Detection. The Third Annual Celebrating Women 2004 Conference, Louisville, Ky. Sept 24th, 2004.

35.

Martin RCG, Evaluation of Topical Recombinant Human Thrombin is a Phase 2 study in patients Undergoing Hepatic Resection. Poster Presentation American College of Surgeons Annual Meeting, San Francisco October 2005.

36.

Helm CW, Martin RS III, Metzinger D, Parker L, Gordinier E, Edwards R. Hyperthermic Intraperitoneal chemotherapy with surgery for recurrent ovarian carcinoma. Society of Gynecologic Oncology Meeting, Palm Springs, CA, March 2006. Gyn Onc 2006, vol. 101, Supplement 1, pg. 174-175.

37.

Martin RCG, Lewis AM, Scoggins CR, Stromberg, AJ, Ellis SF, McMasters KM. Health related quality of life: Return to baseline after major and minor liver resection. International Hepato-Pancreato-Biliary Association 2006 Congress, Edinburgh, Scotland, Sept 3rd-7th.

38.

First Author Oral Presentation SAGES 2007 2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: The Use of Self Expanding Silicone Stents in Esophageal Cancer Care: Optimal Pre-operative, Peri-operative, and Post-operative care.

39.

First Author Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las Vegas, NV: Microwave Hepatic Tumor Ablation Results of ongoing Phase 2 Trial.

40.

Senior Author Oral Presentation at the 115th Scientific Session, Western Surgical Association, Boulder, CO, Nov 2007 Analysis of 900 Appendiceal Carcinoid Tumors with a Proposal for a Staging System.

41.

First Author Oral Presentaiton at the 115th Scientific Session, Western Surgical 69

CURRICULUM VITAE

January 5th, 2014

Association, Boulder, CO, Nov 2007 Arterial and Venous Resection for Locally Advanced Pancreatic Malignancies: Operative and Long-term Outcomes. 42.

First Author Oral Presentation Society of Interventional Radiology Oncology Session, Washington, DC March 19th, 2008: Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug Eluting Beads: Multi-Institutional Study.

43.

Senior Author Oral Presentation at the 116th Scientific Session, Western Surgical Association, Sante Fe, N.M., Nov 11th, 2008. Evaluation of 2,537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging System.

44.

First Author Oral Presentation – Southern Surgical Assocation, December, 2008, The Breakers, West Palm Beach, FL. Simultaneous vs. Staged Resection for Synchronous Colorectal Cancer Liver Metastases.

45.

First Author Oral Presentation at the 95th Annual Clinical Congress – American College of Surgeons, October 12th, 2009, Chicago IL. Analysis of 6,747 Pancreatic Neuroendocrine Tumors for a Proposed Staging System

46.

First Author Oral Presentation – Southern Surgical Assocation, December, 2009, The Homestead, Hot Springs VA. Laparoscopic Hepatic Lobectomy: Advantages of A Minimally Invasive Approach.

47.

Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010, Phase II comparison study of intraoperative autotransfusion for major oncologic procedures.

48.

Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010, Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Optimal Tolerance and Prolonged Overall Survival.

49.

Senior Author Oral Presentation – The Central Surgical Association, March 13th, 2010, Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest Radiography.

50.

First Author Oral Poster Presentation - Treatment of chemo naive colorectal liver metastasis by using irinotecan drug eluting bead with concomiotant systemic fluorouracil and oxaliplatin. 12th World Congress on Gastrointestinal Cancer, June 30th – July 3rd, 2010, Barcelona, Spain.

51.

First Author Presentation - Management of diffuse hepatocellular cancer (≥ 10 lesions) with doxorubicin-loaded DC Bead is a safe and effective treatment option. 12th Congress

70

CURRICULUM VITAE

January 5th, 2014

of the Cardiovascular and Interventional Radiological Society of Europe, Valencia, Spain October 2nd, 2010. 52.

First Author Oral Presentation - Optimal technique of doxorubicin DC Bead in Hepatocellular cancer: small bead vs. large bead, one vial vs. two vials, complete stasis vs. partial stasis. 12th Congress of the Cardiovascular and Interventional Radiological Society of Europe, Valencia, Spain October 2nd, 2010.

53.

Senior Author Oral Presentation – The Southern Surgical Association, Dec 6th, 2010, The Breakers, West Palm Beach, Fl. A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety

54.

First Author Oral Presentation – The American Surgical Association, April 15th, 2011, The Boca Raton Resort and Spa, Boca Raton, Fl. Readmission Rates after Abdominal Surgery: The Role of Surgeon, Primary Caregiver, Home Health, and Sub-acute Rehab

55.

Senior Author Oral Presentation - Asian Pacific HPBA Congress, September 28th, 2011 Melbourne, Australia. Laparoscopic versus Open Resection of Hepatic Colorectal Metastases.

56.

First Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando, FL, March 23nd 2012. Image Guided Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Overall Survival.

57.

Senior Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando, FL, March 24nd 2012. A Deviation Based Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection.

58.

Senior Author Oral Presentation - 69th Annual Meeting of the Central Surgical Association at the Monona Terrace Convention Center in Madison, WI, March 1st, 2012. Laparoscopic Versus Open Resection of Hepatic Colorectal Metastases

59.

Senior Author Oral Presentation – 2012 AHPBA Annual Meeting, Eden Roc Resort, Miami FL, March 7th 2012. Safety and Early Efficacy of Irreversible Electroporation for Hepatic Tumors in Proximity to Vital Structures.

60.

Senior Author Oral Presentation – 2012 Southern Surgical Association, The Breakers, Palm Beach, FL, Dec 4th, 2012. The Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor. 71

CURRICULUM VITAE

January 5th, 2014

61.

Senior Author Oral Presentation – 2013 Southeastern Surgical Congress, Jacksonville, FL, Feb 12th, 2013. Evaluation of AFP Staging System for Hepatocellular Carcinoma in Noncirrhotic Patients.

62.

Senior Author Oral Presentation – 66th Annual Society of Surgical Oncology Cancer Symposium, New Harbor MD, March 8, 2013. Optimal Stroke Volume Variation in Hepatic Resection: A replacement for standard central venous pressure monitoring.

63.

Senior Author Oral Presentation – Central Surgical Association, Amelia Island, FL, March 15th, 2013. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical Efficacy or Limited Benefit?

64.

Senior Author Oral Presentation – Western Surgical Association, Salt Lake Utah, November 5th, 2013 - Single Stage Resection Combined with Microwave Ablation (MW) for the Treatment of Bilobar Colorectal Cancer Metastases: Results from 201 Consecutive Patients compared to two-stage Hepatectomy

65.

First/ Senior Author Oral Plenary Presentation – 2014 Gastrointestinal Cancer Symposium (giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients with Unresectable Colorectal Liver-Limited Metastasis.

66.

First/ Senior Author Poster Plenary Presentation – 2014 Gastrointestinal Cancer Symposium (giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients with Unresectable Colorectal Liver-Limited Metastasis.

67.

First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Differences in toxicity amongst drugs used in hyperthermic intraperitoneal chemotherapy

68.

First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Quality of Life (QOL) Improvement and Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicinloaded beads(DEBDOX) in the treatment of liver metastases from Ocular Melanoma: Results from a Phase I Trial.

69.

First Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association – February 22, 2014 – En Roc, Miami FL. Ongoing Clinical Trial - Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin (Gem-Cis).

72

CURRICULUM VITAE

January 5th, 2014

70.

Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association – February 21st 2014 – En Roc, Miami FL. The role of hepatic artery lymph node (HALN) in pancreatic adenocarcinoma: Prognostic factor or Surgical selection criteria.

71.

Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association – February 21st 2014 – En Roc, Miami FL. Laparoscopic Hepatectomy Significantly Shortens the Time to Postoperative Chemotherapy in Obese Patients Undergoing Major Hepatectomies.

72.

Senior Author Presentation – 2014 Annual Meeting Society of University Surgeons – February 6th 2014 – San Diego, CA - Intra-operative Navigation of a 3-Dimensional Needle Localization System for Precision of Irreversible Electroporation Needles in Locally Advanced Pancreatic Cancer.

73.

Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014 -Southeastern Surgical Congress -Restrictive Blood Transfusion Protocol in Liver Resections Patients Reduces Blood Transfusions with No Increase in Patient Morbidity

74.

Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014 – Southeastern Surgical Congress - GERD-Related Symptom Assessment in Subjects with Malignant Dysphagia receiving Esophageal Stents.

75.

Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st Annual Meeting, March 7th 2014, Indianapolis IN. A Cost Analysis of a Pancreatic Cancer Screening Protocol in High-Risk Populations.

76.

Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st Annual Meeting, March 7th 2014, Indianapolis IN. Borderline and Locally Advanced Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin Accentuation.

77.

First/ Senior Author Oral Presentation – Society of Surgical Oncology 67th Annual Cancer Symposium – Phoenix, AZ – March 13th 2014 - Quality of Life (QOL) Improvement and Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicin-loaded beads(DEBDOX) in the treatment of liver metastases from Ocular Melanoma: Results from a Phase I Trial.

78.

First/ Senior Author Plenary Presentation – Society of Surgical Oncology 67th Annual Cancer Symposium – Phoenix, AZ – March 14th 2014 - Randomized Controlled Trial of Irinotecan Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients with Unresectable Colorectal Liver-Limited Metastasis. 73

CURRICULUM VITAE

January 5th, 2014

79.

Senior Author Oral Presentation - Society of Surgical Oncology 67th Annual Cancer Symposium – Phoenix, AZ – March 14th 2014 Optimal Staging of Pancreatic Neuroendocrine Tumors: Mandatory Grading using Ki67 Index and Mitotic Rate Increases the Prognostic Accuracy of Disease-free Survival and Overall Survival

80.

Senior Author Oral Presentation - Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long Term Gastro-Esophageal Reflux and Quality of Life Related Symptoms – Western Surgical Association 2014 Annual Meeting – Indian Wells, CA Nov 11th 2014

74